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1 . 
Introduction 
 
CORONARY ARTERY ANATOMY 
 
The coronary arteries are major blood vessels branching along the heart surface to convey nutrients and 
oxygen carried in the blood to the heart muscle cells. In turn, the heart ensures the perpetual 
transportation of blood throughout the other organs of the circulatory system. Coronary arteries 
comprise the right and left coronary artery. Both originate from the root of the aorta. The left main 
coronary artery (LCA) gives off the left circumflex artery (LCX) and continues its descent as the left 
anterior descending coronary artery (LAD). The LCX runs around the left border of the heart to reach 
the posterior surface where it supplies the left ventricle muscle. The LAD and its branches supply two 
thirds of the anterior heart surface. The right coronary artery (RCA) descends along the border of the 
right atrium and the right ventricle to supply the right ventricle muscle. A simplified representation of 
the coronary artery anatomy is represented in Figure 1. 
 
 
 
Figure 1. Simplified representation of the coronary artery anatomy. Intra-coronary catheters are inserted  
from the root of the aorta either in the right or left coronary artery. [1] 
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CORONARY ATHEROSCLEROSIS AND 
THE VULNERABLE PLAQUE 
 
Atherosclerosis is a systemic chronic disease of the arterial wall [2, 3]. As late atherosclerosis 
developmental stages can become erratic and lead to ischemia, development of the disease in a major 
nutrient vessel such as a coronary artery can set the stage for a heart attack. Coronary atherosclerosis is 
one of the leading causes of premature death worldwide and results in the loss of productive life years for 
society. 
 
Over the past 20 years, physicians’ vision and understanding of atherosclerosis drastically evolved [4]. 
Atherosclerosis was perceived as the passive accumulation of cholesterol on the arterial wall, leading to 
total vessel occlusion and the subsequent loss of the organ function. Research efforts in the vascular 
biology of atherosclerosis have since revealed dynamic cellular mechanisms that start within the arterial 
wall, where inflammation adversely supports atherosclerotic lesions progression (referred to as plaques) 
from onset till occasionally rupture. The current view is that most adverse cardiac events result from the 
rupture of an atherosclerotic plaque [5] rather than from plaque growth until total vessel occlusion. It is 
the anomalous encounter of plaque content with luminal blood that leads to ischemia via 
thrombogenesis (blood clot formation). 
 
In 1989, Dr. James Muller and colleagues introduced the term "Vulnerable Plaque" to describe a plaque 
at high risk of disruption that leads to coronary thrombosis [6]. The identification of vulnerable 
coronary atherosclerotic plaques, susceptible to rupture and therefore candidates for intervention 
remains today a central issue in cardiac imaging. The terminology of high-risk and vulnerable coronary 
artery plaques was further specified in 2004 [7] but a medical debate on their adequate treatment is 
ongoing [8]. Plaque vulnerability is known to be related to composition, mechanical stress distribution, 
and inflammation state. Several markers of plaque vulnerability were identified [8, 9] and are represented 
in Figure 2 (schematic). In particular, the proliferation inside a plaque of nutrient microvessels (the vasa 
vasorum) is increasingly recognized as critical to plaque progression and may constitute an independent 
marker of vulnerability [3]. The cross section of a vulnerable human coronary atherosclerotic plaque is 
displayed in Figure 2. 
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Figure 2. (Left) Markers of plaque vulnerability [10]. (Right) Histology of a human coronary artery 
vulnerable plaque (thin-cap fibroatheroma). Such a plaque configuration, that exhibits a large lipid pool 
covered by a thin fibrous cap (arrow), is associated with a high risk of rupture. The lumen appears white. 
NC stands for necrotic core (lipid rich region). [11] 
 
CORONARY ATHEROSCLEROSIS MONITORING AND 
INTERVENTION 
 
The standard procedure to visualize the entire coronary anatomy is coronary angiography. The technique 
consists in the real-time acquisition of X-ray images of the heart (angiograms) after the release of an X-
ray contrast fluid by means of an intracoronary catheter. Angiography provides two dimensional 
projections of intracoronary blood volume which enables the localization of obstructed blood flow as 
well as the quantification of the degree of stenosis at these locations. It is important to realize that 
because it visualizes blood, coronary angiography informs on the luminal geometry of coronary arteries. 
Coronary angiography has a spatial resolution of 200 μm and temporal resolution of 5 ms [12]. In some 
case, coronary angiography can be ambiguous in detecting atherosclerotic plaques. Glagov et al. reported 
in 1987 that “many persons have an adequate, if not normal, lumen cross-sectional area in the presence of 
advanced atherosclerosis and that such a possibility should be taken into account in evaluating the extent  
and severity of disease with angiography” [13]. These observations demonstrated the need for techniques 
capable of imaging the coronary wall with a high resolution, as illustrated in Figure 3. 
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Figure 3. Local intravascular ultrasound images (A to D) detect the presence of coronary atherosclerosis 
plaques in the arterial wall, invisible in coronary angiography (left). [15] 
 
 
The standard procedure for the treatment for symptomatic coronary atherosclerosis is to perform a 
percutaneous coronary intervention (PCI). A stent folded at the tip of a catheter is navigated under 
coronary angiography guidance to the coronary artery stenosis site. A stent is released in contact with the 
arterial wall in order to maintain the artery lumen open, which restores the impaired blood flow and 
prevents ischemia. Recently, bioresorbable stents (or scaffolds) were introduced to limit post-treatment 
complications such as late stent thrombosis observed with metal stents [14]. 
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INTRAVASCULAR ULTRASOUND (IVUS) 
 
Intravascular ultrasound (IVUS) is a catheter-based echocardiography modality that was invented at 
Erasmus MC in 1972 [16]. Twenty years later, IVUS was developed for its capacity to image the 
coronary artery wall with high resolution. IVUS technology consists in a miniaturized echography unit 
mounted at the tip of a catheter that is either made of a single piezoelectric transducer (40 to 60 MHz 
range) or of a 64 transducers circular array (20 MHz). IVUS catheters are side looking devices that 
display radial images perpendicular to the catheter axis. Single transducer IVUS images are acquired by 
mechanically rotating the transducer over 360 degrees while in circular array IVUS the ultrasound beam 
is steered electronically. IVUS image resolution is of the order of 100 μm in the axial direct (frequency 
dependent) and 300 μm in the lateral direction (transducer diameter dependent). In clinical practice, 
catheters are advanced through the groin until the root of the aorta and entered directly into the left or 
right coronary artery to inspect the status of the arterial wall. In vivo images of inner artery wall 
structures such as atherosclerotic plaques are created this way (Figures 2 and 3). IVUS has been used 
initially to ensure a more accurate local diagnosis of coronary atherosclerosis, since X-ray angiography can 
be ambiguous. Later on, IVUS played an important role in the standardization of balloon angioplasty 
and stent treatments. To date, prominent interventional cardiologists advocate IVUS guided PCI 
interventions [17]. IVUS provides plaque morphology, plaque burden, luminal diameter before 
intervention and helps defining optimal stent dimensions. After intervention, proper stent apposition 
can be controlled and potential complications can be assessed using IVUS (e.g. thrombus formation). 
IVUS technology also proved to be very useful in clinical trials. Since plaque progression and regression 
can be accurately measured with IVUS, the efficacy of new cardiovascular drugs can be assessed. The 
most valued IVUS functions are the estimation of the total plaque burden [18] (thanks to the 
delineation of the external elastic membrane) as well as calcium detection (Figure 4). Furthermore, IVUS 
penetration depth is sufficient to image side branches and large vessel diameters such as the left main 
coronary artery. 
 
Yet, to predict the risk for future acute cardiovascular events, the knowledge of plaque composition is 
critical [20] but is not provided by conventional IVUS. Several modalities have been derived from IVUS 
radiofrequency signal analysis to enhance the detection and characterization of high risk coronary artery 
plaques, notably IVUS flow and IVUS palpography. The principle of IVUS flow is based on the analysis 
of decorrelation of the IVUS radiofrequency signals [21]. Red blood cells flowing in the ultrasound beam  
cause a decorrelation of successively received signals. 
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Figure 4. (A) An example of calcified nodule, (B) fibroatheroma, and (C) calcified fibrosis (non-nodular 
calcium) by pathology (top) and IVUS (bottom). (A) Pathology of calcified nodule (Movat pentachrome stain) 
shows calcified nodule (dark brown) with accumulated fibrin (red) protruding into the lumen through a 
disrupted thin fibrous cap (arrow). IVUS of the calcified nodule shows a convex and irregular (nonsmooth 
and lumpy) luminal surface (arrowhead). (B) Pathology of late fibroatheroma shows luminal narrowing with 
necrotic core. (C) Pathology of non-nodular calcium shows a lump of calcium (dark purple, arrow). IVUS 
shows a smooth concave luminal/calcified surface with high echogenicity (arrow). [19] 
 
The principle of IVUS flow is based on the analysis of decorrelation of the IVUS radiofrequency signals 
[21]. Red blood cells flowing in the ultrasound beam cause a decorrelation of successively received signals. 
The rate of decorrelation is proportional to the local blood flow velocity. These are then converted into 
color maps representing local instantaneous blood flow velocity in the arterial cross section. A color 
scheme is used, going from dark red (10 cm/s) to yellow (100 cm/s). Flow velocities are measured at 100 
angular positions, with a depth resolution of 160 μm (Figure 5). Blood velocity and volumetric flow are 
valuable criteria to assess the severity of a stenosis. 
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Figure 5. IVUS flow in the renal artery of a human patient [22]. Blood flow is mapped is red at different 
phases of the heart cycle. IVUS volumetric flow (green curve) was found is good agreement with Doppler 
volumetric flow (blue curve). 
 
IVUS palpography capitalizes on the arterial wall deformation induced by the pulsatile intraluminal cardiac 
pressure. Since the strains in the radial and circumferential direction are the principal directions, there is a 
great benefit of using intravascular catheters; the ultrasound beams are more or less in the radial direction 
whereas the circumferential strain can be determined from displacements perpendicular to the ultrasound 
beams. For acquiring an intravascular elastogram, an IVUS catheter is inserted in a coronary artery and 
radiofrequency signals are recorded for the full circumference at low and high intraluminal pressure. Radial 
displacements are calculated by applying cross-correlation technique to each separate ultrasound line. From 
the displacements, the strain is calculated and plotted next to the IVUS echograms (Figure 6).  
 
Strain information can also be visualized by overlaying simply the inner ring of strain values (the 
eventually rupture prone region) in IVUS image at the lumen vessel wall boundary [24]. Such an image is 
referred to as a palpogram and can be used to differentiate vulnerable plaques from stable ones. The IBIS-
2 clinical trial reported that patients with vulnerable plaques that were treated with the inhibitor of an 
enzyme associated with inflammation activity showed a significant decrease in strain values in 12 months’ 
time [25]. 
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Figure 6. In vivo IVUS image of a human coronary plaque and corresponding elastogram. The elastogram 
reveals that the plaque has deformable edges with non-deformable surrounding tissue. High strain regions 
at the shoulders of a plaque are an indication of vulnerability, often related to the infiltration of 
macrophages. [23] 
 
IVUS DETECTION OF INTRAPLAQUE VASA VASORUM 
 
Larger blood vessels such as the coronary arteries require their own blood supply. It is provided by a 
network of microvessels that penetrate the inner layers of the arterial wall. This microvascular network is 
referred to as the vasa vasorum [26]. It is increasingly recognized that the progression of atherosclerotic 
plaques is associated with the development of neovascular vasa vasorum through the process of 
angiogenesis. This hypothesis was recently supported by 3D micro-CT images of ex vivo coronary 
arteries [27] as shown in Figure 7. To date however, there is no established clinical technique capable of 
imaging coronary vasa vasorum in vivo. 
 
 
 
 
 
 
 
 
Figure 7. 3D micro computed 
tomography image of an ex vivo 
human coronary artery plaque. Vasa 
vasorum proliferation is visible in the 
plaque area. [28] 
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Exploratory work combining IVUS with an ultrasound contrast agent laid the foundation for what could 
be a unique clinical tool for coronary artery vasa vasorum imaging. An ultrasound contrast agent is a 
suspension of high molecular weight gas microbubbles encapsulated by thin lipid shells. Bubbles are 
typically designed to be of a size (1-10 μm) that passes through capillary beds and are acoustically active at 
diagnostic ultrasound frequencies. The primary advantages of using ultrasound contrast agents are the 
improvement of the signal strength from blood, which becomes bright in echographic images (a parallel 
can be drawn with bright blood pulse sequences in magnetic resonance imaging), and the detection of 
slow microvascular flow in the presence of tissue motion. Several studies reported extra-luminal image 
enhancement following the bolus injection of contrast agent, which has been attributed to the presence 
of vasa vasorum [29, 30]. The basis of this approach was to compare post-contrast injection images with a 
baseline image derived from a single point in the cardiac cycle. While these results were promising, the 
sensitivity and robustness of this method ultimately relied upon the assumption of similarity between 
images acquired at the same point in the cardiac cycle and, as such, was susceptible to acyclical catheter-
vessel motion or non-uniform rotation velocity of the IVUS transducer. Nonetheless, this work 
motivated the development of contrast IVUS detection techniques based on bubble-specific signatures. 
Goertz et al. demonstrated the feasibility of nonlinear contrast IVUS for vasa vasorum imaging using a 
prototype IVUS transducer with a double frequency peak [31, 32]. Contrast mode images of blood 
circulation could be displayed by isolating the nonlinear second harmonic or subharmonic echoes 
backscattered by the ultrasound contrast agent as shown in Figure 8. 
 
 
 
Figure 8. In vivo contrast IVUS image of an atherosclerotic rabbit aorta using decanted Definity. Left: 
fundamental mode at 20 MHz, 10 s after injection, in which changes in adventitial enhancement are not 
evident. Right: at 10 s after injection, the harmonic mode (transmit at 20 MHz, receive at 40 MHz) shows 
significant adventitial enhancement, consistent with the detection of adventitial microvessels. The white 
dots are contrast microbubbles in the vasa vasorum (white arrows), and the bright ring, contrast 
microbubbles inside the lumen (asterisk). Scale of images is 12 mm across. The dynamic range of the 
fundamental and harmonic image is 40 and 25 dB, respectively. 
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While these initial results were very promising, a great deal of work remains before contrast-enhanced 
IVUS imaging can be adopted in the clinic. Despite a good sensitivity, the prototype transducer utilized 
by Goertz et al. suffered from a lower spatial resolution than conventional clinical IVUS, because of the 
narrow bandwidth of its two frequency peaks (two-way 30% -6 dB relative bandwidth). It also became 
evident that existing IVUS catheters are far from optimal for the primary goal of vasa vasorum imaging. 
The bandwidth and sensitivity of commercial IVUS transducers is not adequate for second harmonic and 
subharmonic imaging (a -6 dB relative bandwidth of the order of 70% is required). In addition, nonlinear 
ultrasound propagation in biological tissue generates second harmonics that impair the specificity of 
second harmonic contrast imaging [32]. And subharmonic contrast IVUS imaging, which has been 
demonstrated with a tailored contrast agent size distribution, still needs to be evaluated with a 
commercial ultrasound contrast agent distribution. 
 
THESIS OUTLINE 
 
This thesis gathers in a comprehensive unit the principal contributions to the field of intravascular 
ultrasound vasa vasorum imaging that were achieved as a part of the Simon Stevin Meester grant 2007. 
The ambition was to develop and validate robust quantitative contrast IVUS imaging techniques able to 
establish the microvascular status of coronary atherosclerotic plaques. Furthermore, research efforts 
should be directed towards translation into clinical practice. 
 
Chapter 2 presents a single transducer technique that capitalizes on the behavior of individual 
ultrasound contrast microbubbles at IVUS frequency to estimate the size distribution of an ultrasound 
contrast agent acoustically. It could help studying the retention of microbubbles that occurs in vivo in 
organs as the lungs and the kidneys. 
 
Chapter 3 reports the 3D reconstruction of a vasa vasorum phantom using a commercial ultrasound 
contrast agent in combination with commercial IVUS equipment. This short study was thought as a 
tutorial that highlights the limitations of current IVUS systems in terms of nonlinear contrast imaging. 
Since the IVUS catheter bandwidth did not allow second harmonic or subharmonic imaging, the system 
was operated at the fundamental frequency. A non-diluted bolus of ultrasound contrast agent was needed 
to differentiate microbubbles from tissue. The drawback was that the contrast agent signal was saturated, 
rendering any quantitative hemodynamic assessments impossible. 
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Chapter 4 introduces chirp IVUS imaging and discusses its potential for both tissue and contrast 
imaging. Higher signal to noise ratios were achieved at equal peak negative pressure than conventional 
imaging pulses, translating into superior IVUS penetration depth and thus enhanced plaque burden 
assessment capabilities. Moreover, a chirp specific contrast imaging mode was successfully implemented 
on a conventional bandwidth-limited IVUS transducer. 
 
Chapter 5 compares the performance of two novel narrowband contrast IVUS vasa vasorum imaging 
techniques, chirp reversal IVUS and ultraharmonic IVUS, that can operate within the bandwidth 
limitations of commercial IVUS transducers. 
 
Chapter 6 reports the first in vivo IVUS image of a microvascular network and compares its accuracy to 
an optical reference measurement. The approach combines the superior sensitivity of chirp excitations 
with the specificity of ultraharmonics to deliver a robust artifact-free contrast-enhanced IVUS modality 
capable of detecting microvasculature invisible in conventional intracoronary imaging. Ultraharmonic 
IVUS has emerged as a promising method for the detection of coronary plaque neovascularization in 
humans. 
 
Chapter 7 confronts the IVUS biomedical engineering research exposed in this thesis to the results of a 
sociology study of IVUS innovation. A representative network of experts with experience in IVUS was 
surveyed, comprising cardiologists, engineers, industry leaders and funders. We discuss the potential of 
IVUS technology and its future in light of the controversies conveyed by this international network of 
experts. 
 
Chapter 8 concludes this thesis and suggests possible technological advances in the field of IVUS. 
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Acoustic Sizing of an 
Ultrasound Contrast Agent 
 
Based on the publication by D. Maresca, M. Emmer, P. L. van Neer, H. J. Vos, M. Versluis, M. Muller, N. de 
Jong, A. F. van der Steen, Acoustic Sizing of an Ultrasound Contrast Agent. Ultrasound in Medicine & 
Biology 36, 1713-1721 (2010). 
 
ABSTRACT 
 
Because the properties of ultrasound contrast agent populations after administration to patients are 
largely unknown, methods able to study them noninvasively are required. In this study, we acoustically 
performed a size distribution measurement of the ultrasound contrast agent Definity. Single lipid-
shelled microbubbles were insonified at 25 MHz, which is considerably higher than their resonance 
frequency, so that their acoustic responses depended on their geometrical cross sections only. We 
calculated the size of each microbubble from their measured backscattered pressures. The acoustic size 
measurements were compared with optical reference size measurements to test their accuracy. Our 
acoustic sizing method was applied to 88 individual Definity bubbles to derive a size distribution of this 
agent. The size distribution obtained acoustically showed a mean diameter (2.5 μm) and a standard 
deviation (0.9 μm) in agreement within 8% with the optical reference measurement. At 25 MHz, this 
method can be applied to bubble sizes larger than 1.2 μm in diameter. It was observed that similar sized 
bubbles can give different responses (up to a factor 1.5), probably because of shell differences. These 
limitations should be taken into account when implementing the method in vivo. This acoustic sizing 
method has potential for estimating the size distribution of an ultrasound contrast agent noninvasively. 
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INTRODUCTION 
 
Encapsulated gas microbubbles, the constituents of medical ultrasound contrast agents (UCAs), are 
increasingly used clinically because they showed strong potential for organ perfusion diagnostics, capillary 
networks imaging and local therapy including drug or gene delivery and sonothrombolysis [33-35]. 
Commercial UCAs consist of bubble populations ranging from 0.5-10 μm in size and usually exhibit a 
mean diameter of 1-3 μm. Ultrasound contrast imaging techniques rely largely on the nonlinear 
scattering of contrast microbubbles [36, 37]. Bubble size has a great impact on the generation of higher 
harmonic energy scattered by an UCA [38, 39]. Microbubbles enhance echo contrast the most at their 
individual resonance frequencies. As an example, Definity contrast bubbles (Lantheus Medical Imaging, 
Inc., North Billerica, MA, USA) are estimated to have a resonance frequency of 75 MHz for a bubble 
diameter of 0.5 μm, 27 MHz for a diameter of 1 μm and 10 MHz for a diameter of 2 μm [40]. Thus, 
ultrasound contrast imaging techniques benefit from different sized groups of an agent population 
depending on the frequency of the ultrasound field applied [41]. Contrast echocardiography or contrast 
liver imaging work in the 1-7 MHz range [42, 43], whereas contrast intravascular ultrasound [31, 32, 44] 
works in the 20-40 MHz range. Therefore, it is important to know the size distribution of an UCA. 
Standard particle size analyzers used to measure an UCA size distribution in vitro can be based on to the 
change of electric conductance of particles in a solution (Coulter principle), on laser diffraction of these 
particles (e.g., Mastersizer 2000, Malvern Instruments Ltd., Worcestershire, UK) or on the optical 
scanning of an agent population using a microscope [45]. However, the size distribution of UCA 
populations after human administration is unknown. Factors such as the gas concentration of the 
bubbles inside the body, the temperature elevation to 37°C [46] and the lung filtering of the largest 
bubbles [47, 48] make comparison with in vitro size distribution measurements unreliable. It is therefore 
of interest to offer experimental methods to measure UCA size distributions noninvasively [49]. 
Newhouse and Mohana Shankar [50] presented an ultrasound based double-frequency method of sizing 
bubbles, already envisioning the study of contrast agents for echocardiography as a potential application. 
Gas bubbles respond to a dual-frequency excitation by returning a signal at plus and minus the two 
frequencies, at resonance only. From the knowledge of the resonance frequency of a gas bubble, the radius 
can be readily determined. This idea was developed further [51] and an instrument to size and analyze 
bubbles with this technique was built and tested [52]. However, this double-frequency technique needs 
at least two transducers and was applied to size bubbles bigger than 30 μm only. Leighton et al. [53] 
suggested to size bubbles using ultrasound by applying eight different ultrasound methods 
simultaneously (e.g., broadband scattering, fundamental or harmonic scattering, two frequencies mixing 
at resonance). The limitations and advantages of the different methods compensate each other, providing 
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a sharper size estimation. The approach was successfully applied to a single gas bubble of radius 0.9 mm. 
None of these studies used high-frequency ultrasound (>10 MHz). Unfortunately, the resonance 
frequency of an encapsulated bubble is not an unambiguous determinant of its size because of the shell 
influence. Other research groups developed methods to determine the size distribution of lipid-shelled 
bubble clouds in vitro by fitting attenuation or backscattering simulations to their experimental acoustic 
pulse attenuation or scattering measurements [54, 55]. In this study, we suggest inspecting bubbles high 
above their resonance frequencies. In this condition, bubble responses depend on their geometrical cross 
section only, quasi-independent from their shell elasticity and viscosity [56]. Our objective was to take 
advantage of this feature to measure single bubble radii using ultrasound in pulse-echo mode. Such a 
noninvasive method can potentially be exploited to estimate the size distribution of an UCA in vivo. An 
acoustic sizing method was developed in our laboratory and applied to a population of 88 individual 
Definity bubbles. The result is compared with an optical size measurement of the same bubbles. The 
theoretical background of this method is introduced and particular attention is given to the 
measurement system and its calibration, which enabled the derivation of the size of an UCA bubble from 
its echo amplitude. 
 
THEORETICAL BACKGROUND 
 
In this section, we are going to derive the equation to determine a bubble radius out of the acoustic 
pressure impinging on that bubble, the acoustic pressure scattered back by the bubble and the bubble-
transducer distance. A gas bubble of radius R, insonified by an ultrasound wave of wavelength λ, scatters 
an omnidirectional pressure wave if R << λ is assumed. The power scattered by the bubble, Ps, relates to 
the incident wave intensity, Ii, as Ps = σIi, where σ is the acoustic scattering cross section [57]. The 
intensity scattered by a point source is equal to the quotient of the scattered power and the spherical 
surface at distance z. For a spherical gas bubble, the incident and scattered intensities relate as: 
 
24 z
II is pi
σ
=             (1) 
 
where Is is the scattered intensity. For harmonic plane waves, the intensity can be formulated as the 
quotient of the acoustic pressure squared divided by twice the acoustic impedance. Thus equation (1) can 
be rewritten as: 
 
is p
z
p
pi
σ
4
1
=            (2) 
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where pi is the incident pressure that hits the bubble and ps the pressure scattered by the bubble. Medwin 
[57] has shown that the acoustic scattering cross section of a gas bubble in a liquid environment is 
expressed in the linear regime as: 
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where f is the frequency of the applied ultrasound field, f0 the resonance frequency of the bubble and δ the 
total damping. This equation is also valid for encapsulated bubbles in the linear regime. The damping δ2 
for the microbubbles in this study is assumed to be much smaller than 1 [40, 58]. It follows that for f >> 
f0, the acoustic scattering cross section becomes a function of R only:  
 
( ) 24, RfR piσ =            (4) 
 
Combining eqns (2) and (4) at the bubble wall leads to: 
 
)()( RpRp is =            (5) 
 
The scattered pressure is equal to the incident pressure at the bubble wall. As R << λ, the pressure 
distribution over the bubble wall is homogeneous and the pressure wave is scattered equally in every 
direction. The pressure scattered at a distance z can be calculated using energy conservation in a lossless 
medium: 
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Combining eqns (5) and (6), the bubble radius is expressed as: 
 
)(
)(
Rp
zp
zR
i
s
=             (7) 
 
Equation (6) states that, for f >> f0, the radius of a bubble can be derived from its backscattered pressure 
once the distance and the pressure impinging on the bubble wall are known. This holds for lipid-shelled 
bubbles as well as gas bubbles. 
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METHODS 
 
Measurement system overview | The combined optical and acoustic single-bubble size measurement 
setup (Fig. 1) consisted of an arbitrary waveform generator (AWG520, Tektronix, Beaverton, OR, USA) 
and a 60 dB RF linear power amplifier (LPI-10, ENI, Rochester, NY, USA) linked to generate and 
amplify the transmit pulses (25MHz, 30% bandwidth Gaussian pulses). A low-noise amplifier (Miteq, 
Hauppauge, NY, USA) amplified the received signals by 60 dB. These were then digitized at 200 MHz 
by a 12 bit A/D PCIcard (DP310, Acqiris, Geneva, Switzerland). A 25 MHz single-element focused 
transducer (Panametrics NDT, 1-inch focus, 54% -6 dB bandwidth; Olympus NDT, Waltham, MA, 
USA) was mounted to a water tank. The UCA Definity was injected with a syringe in a 200 μm 
diameter cellulose capillary (Spectrum Laboratories Inc., 132294, Breda, The Netherlands), which 
crossed the transducer beam focus inside the water tank. The tank holding the transducer and the 
capillary was placed on the translation stage of a microscope (Olympus BH-2 research microscope, 
Olympus Corporation, Zoeterwoude, The Netherlands) equipped with a water immersion objective lens 
(Olympus LUMPLFLN 40XW, N.A. 0.8) focused on the capillary tube. A charge-coupled device 
(CCD) camera (Lm165M, Lumenera Corporation, Ottawa, ON, Canada) was mounted on the 
microscope and used to record images of the capillary region of interest, where both the microscope and 
the acoustic beam were in focus. An optical fiber was fixed below the water tank to illuminate the 
microscope focal plane with a continuous light source. 
 
Figure 1. Schematic overview of the experimental setup for optical and acoustical sizing of microbubbles, 
using an acoustically and optically transparent capillary tube. 
 
Transducer calibration | To measure the incident pressure received by a bubble at the transducer focus, 
as well as the pressure backscattered by the same bubble on the transducer surface, the transducer was 
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carefully calibrated both in emission and in reception. This complete characterization was performed at 
25 MHz based on two independent measurements. First, a calibrated hydrophone setup (75 μm 
polyvinylidene fluoride needle hydrophone, Precision Acoustics Ltd., Dorchester, Dorset, UK) was used 
to measure the pressure at focus and to determine the transmit transfer function of the transducer [59]. 
For our experimental conditions, we measured a pressure at focus of 390 kPa and a transmit transfer 
function of 3.2 kPa/V. The uncertainty of the hydrophone at 25 MHz was ±12%. Note that the 
calculation of this transmit transfer function was done using a transducer gain corrected for water 
attenuation. Our transducer had a focal distance of 2.6 cm that resulted in an attenuation in water of 3.3 
dB at 25 MHz. Second, a pulse-echo setup, using a flat aluminum reflector at the transducer focus, 
enabled the measurement of the product of the transmit transfer function and the receive transfer 
function of the transducer [59]. By combining the results of these two measurements, we derived the 
receive transfer function, which was 26.0 μV/Pa. The knowledge of the receive transfer function, Rt, at 25 
MHz made the conversion of the digitized backscattered bubble echoes into pressure values possible. To 
determine the pressure variation near the focal spot of the transducer beam, we performed a lateral beam 
profile at focus. The measurement was compared with a Field II simulation [60]. Figure 2 shows both the 
simulation and the experiment. The pressure drops by 1 dB 80 μm away from the absolute focus. Because 
the hydrophone chosen for this study exhibits a diameter in the order of a wavelength at 25 MHz, we 
calculated the spatial averaging that will affect the incident pressure field estimates. Following the theory 
detailed by Radulescu et al. [61], together with our Field II simulated pressure values, we obtained a 
pressure drop at focus of 0.12 dB because of spatial averaging. Thus, we concluded that spatial averaging 
has a negligible impact on our study. 
 
 
Figure 2. Comparison of the experimental lateral beam profile at focus of the 25-MHz transducer (dotted 
circled curve) with its simulated profile (dotted curve). 
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Circuit characterization in reception | The transducer receive transfer function, Rt, was defined [59] as: 
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where VTxopen is the open circuit voltage produced by the transducer and ps the pressure backscattered by a 
bubble on the transducer surface. To obtain VTxopen, the received amplitudes have to be converted from 
digitizer voltages to open circuit voltages. The receive chain of the circuit consisted of the transducer 
connected to the expander/limiter, the low-noise amplifier, a band-pass filter (3 to 35 MHz, fifth-order 
Butterworth) and the digitizer. The reception circuit is represented in Fig. 3. We can link the 
backscattered pressure, ps, to the digitizer voltage, Vd, by: 
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where ZT is transducer electric impedance, Zc the receive circuit impedance, Vc the received signal voltage 
before amplification and TVd → Vc the transfer ratio accounting for amplification, the filter and the coaxial 
cables. We measured with a vector impedance meter (4193A, Hewlett Packard, Yokogawa, Japan) ZT 
and ZC and found 46.9 Ohms and 40.7 Ohms, respectively. TVd → Vc was measured by linking the 
reception circuit to the AWG520 and simulating a received pulse of 1.1 mV amplitude. We found a 
corresponding voltage of 200 mV. We derived from these measures that TVd → Vc, which is equal to the 
ratio of Vd over Vc, and obtained a value of 182. The knowledge of ZT, Zc, TVd → Vc and Rt fully 
characterized the circuit in reception and allowed the exact conversion of the digitized bubble echoes 
from voltage amplitudes into real pressures. 
 
 
 
Figure 3. Schematic overview of the receive circuit. Vd is the voltage at the digitizer leads and Vc the voltage 
at the input. ZT is transducer impedance and ZC the receive circuit impedance. 
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Optical and acoustic size measurements | A low concentration of Definity microbubbles was injected 
into the capillary using a syringe, to have no more than one bubble per capillary section of 200 μm. The 
flow in the capillary was controlled using a manual syringe pump. Thanks to that flow control, single 
bubbles were kept one by one in the capillary region of interest, where both the transducer beam and the 
microscope are focused. For each single bubble studied, 64 RF signals were recorded. Simultaneously, an 
image of the corresponding bubble was captured with the CCD camera. The size of the bubble of interest 
was determined from the microscope image using a minimum-cost algorithm that delimits the contour of 
the bubble by finding the steepest grayscale gradient in a box set around the bubble (Fig. 4). The optical 
observation of the diameters before and after insonification revealed no alteration of the bubble sizes. 
The systematic error on the optical size measurement of a bubble was estimated by using a calibrated grid 
displaying dot patterns (DA020, Max Levy Autograph, Philadelphia, PA, USA). The algorithm was used 
to measure the size of 20 calibrated dots from the grid, and the variation of the results was investigated. 
The random error was estimated by sizing the same bubble on different images. Combining the random 
and the systematic error, we quantified the uncertainty of the optical size measurement to be 0.2 μm. The 
acoustic sizing was based on the accurate knowledge of the distance between the bubble of interest and 
the transducer, the pressure at the transducer focus (390kPa) and the pressure backscattered by that 
bubble on the transducer surface. The bubble-transducer distance was derived from the time of flight of 
the digitized bubble echoes. The backscattered pressures were determined as follows. For each bubble 
studied, 64 RF signals were acquired. Because the capillary flow could not be completely stopped, the 
bubbles of interest were moved back and forth around the highest echo position using the manual syringe 
pump. This movement had a typical amplitude of 50 μm. Among the 64 signals acquired per bubble, one 
had the highest amplitude. That signal was chosen because it corresponds to the closest position of a 
given bubble from the exact transducer beam focal point. These selected backscattered amplitudes were 
converted into a pressure value knowing the receive transfer of the transducer. We evaluated the 
uncertainty of the acoustic size measurement to be 24% of the estimated bubble diameter, which 
corresponds to an error of 0.7 μm for a bubble of 3 μm. It originates from the 12% uncertainty of the 
incident and scattered pressure values. The uncertainty of the bubble transducer distance was negligible. 
 
 
Figure 4.  
Contour detection of a contrast bubble for optical sizing. The red curve 
corresponds to the steepest color gradient detection and the blue contour 
is the best circular fit from the red contour. 
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RESULTS 
 
Experimental and simulated basckattered pressures | A set of 88 Definity microbubbles was 
characterized both optically and acoustically. The experimental backscattered pressure values were 
plotted as a function of the optical reference diameters and compared with theory (Fig. 5). We calculated 
the time responses of individual bubbles using the nonlinear Marmottant model [62] and derived the 
theoretical backscattered pressure values from these time responses. The input for the simulation were  
Definity shell parameters determined in our frequency range [40] combined with our experimental 
settings (25 MHz, 390 kPa at transducer focus, transducer-tobubble distance of 2.6 cm). The 
experimental data points showed the linear trend expected above resonance from the simulation. Note 
that for a given bubble diameter, the amplitude of the scattering varied up to a factor 1.5, which is in 
agreement with previous findings [63]. 
 
 
Figure 5. Comparison of the theoretical and experimental backscattering of individual Definity

 
microbubbles as a function of their diameters. The blue circles represent the 88 experimental data points, 
the red curve is the linear fit of the experimental data and the gray curve is the behavior predicted by the 
nonlinear Marmottant model. 
 
Size distributions | The size distribution obtained with our acoustic method resulted in a mean 
diameter of 2.45 μm and a standard deviation of 0.85 μm. As a comparison, the optical characterization 
of the same 88 microbubbles featured a mean diameter of 2.67 μm and a standard deviation of 0.78 μm. 
In terms of medians, the acoustic distribution exhibits a value of 2.22 μm and the optical one a value of 
2.55 μm (Table 1). The maximum diameter measured acoustically was 6.2 μm and corresponds to an 
optical diameter of 5.5 μm. The minimum acoustic diameter measured was 1.4 μm and the optical one 
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measured 1.7 μm. As a comparison, Lantheus Medical Imaging claims for Definity a mean diameter 
range of 1.1-3.3 μm and a percentage of bubbles showing a diameter inferior to 10 μm of 98%. The 
acoustic diameters and the optical ones are compared in Fig. 6, showing a correlation coefficient of 0.9. 
The optical and acoustic size distributions are represented in Fig. 7. The diameter range of the optical 
distribution was divided into 20 columns, resulting in a bin size of 0.20 μm. The same bin size was used 
for the acoustic size distribution. 
 
Table 1. Comparison of the optical and acoustic size measurement of 88 Definity

 microbubbles 
 
 
 
DISCUSSION 
 
The individual microbubble diameters measured acoustically show a very good agreement with the 
diameters measured optically, which validates our acoustic sizing method. The experimental data follows 
the expected linear scattering trend above resonance. The agreement with the Marmottant model, using 
Definity shell parameters in the frequency range 12-28 MHz, is excellent. This work also exhibits an 
unexpected spread of the data points that is not predicted by the current model. We observed a 
maximum deviation of a factor 1.5 relative to the model. For the smallest bubbles measured, which have a 
resonance frequency close to 25 MHz [40], the data confirms that lipid-shelled gas bubbles of equal size 
show scattering variations in amplitude [63]. Our sizing approach would benefit from the development 
of lipidshelled bubbles that have equal scattering properties at a given size, contrary to the bubbles used in 
this study. Moreover, the choice of the ultrasound frequency of investigation will determine the smallest 
bubbles that can be sized accurately, because bubbles smaller than a certain size will violate the linear 
scatterer assumption. For Definity and at 25 MHz, we can establish sizes greater than 1.2 μm diameter 
[40]. By increasing the ultrasound frequency of investigation, smaller bubble sizes can be measured. The 
acoustically determined size distribution is comparable in shape with the optical one. The acoustic size 
distribution appears slightly wider in terms of diameter range and shifted towards the lower radii by 8%. 
The ±12% uncertainty of the hydrophone used to calibrate the transducer is thought be one of the 
reasons for the observed global shift, because the calibration of the transducer sensitivity in reception 
governs the bubble size estimation. 
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Figure 6. Correlation between the acoustic and the optical diameters determined experimentally. 
 
The total damping, which was neglected in this study, can also have a small impact on the distribution 
because its contribution increases with bubble size. For Definity bubble diameters of 1.3 μm and 6 μm, 
which are the boundaries of our size measurement range, the total damping squared was estimated, 
respectively, to be 0.02 and 0.1 using the equations used by Goertz et al. [40]. Local disparities between 
the two distributions partly originate from the scattering variations of lipid-shelled microbubbles for a 
given size. If a bubble is not scattering at its full potential, it will “sound” like a smaller one. Other factors 
may explain the remaining differences between these two measurements. First, a tube made of cellulose 
was used because this material absorbs a large amount of water and is expected to have an acoustic 
impedance matching reasonably well with water. However, the capillary influence on the pressure value 
measured with the hydrophone at the transducer focus is not accurately known. Each ultrasound pulse 
travels twice through the cellulose wall of the capillary (transmission and reception), which may cause an 
attenuation of the ultrasound waves and which would tend to globally shift the acoustic distribution 
toward lower radii. Second, the pressure amplitude along the cross section of the capillary tube is not 
distributed homogeneously. To verify that experimentally, we inserted a 30 μm tungsten wire in a 200 
μm cellulose capillary and compared the amplitude of the echo backscattered by the system wire plus 
capillary with the echo amplitude of the tungsten wire alone. We measured an increase in amplitude of a 
factor 1.9, with 20 MHz Gaussian pulses of 50% bandwidth for the system wire plus capillary. Others 
such as Qin et al. [64] simulated for different tube materials that the peak pressure within the tube can 
rise up to 300% of the incident pressure amplitude. As a consequence, the bubbles might have been 
excited at higher or lower pressures than 390 kPa, depending on their exact position in the tube during 
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data acquisition. Another parameter difficult to control was the position of the bubble under 
consideration along the tube axis. Each candidate was kept in the transducer focal region but the position 
of the bubble was not stable during the acoustic data acquisition. If the bubble of interest was not located 
at the focal point where the pressure was measured with the hydrophone, it received an incident pressure 
slightly lower than the pressure expected at focus. Experimentally, the beam profile of the transducer tells 
us that at a lateral distance of 80 μm from the focus, the pressure amplitude drops by 1 dB only. We 
solved this problem by selecting the highest echo amplitude out of the 64 acquired per bubble, because 
the maximal scattering will occur at the transducer focal point. Experimentally, the bubble of interest was 
kept in the ultrasound beam focal region using a manual syringe pump and going back and forth around 
the maximum scattering position. The acoustic bubble sizing method presented in this study proved to 
be competitive in determining the size distribution of an UCA. It benefits from the usual advantages of 
ultrasound imaging techniques, e.g., potentially real-time, noninvasive, harmless for the patient and 
affordable.  
 
 
 
Figure 7. Optical (top) and acoustic (bottom) size distributions of the same population of 88 Definity

 
bubbles. 
 
Despite the current work focused on studying a lipid-shelled ultrasound contrast agent, the technique 
could be applied to any type of gas bubbles, independent of the nature of their shell because only the 
geometric scattering of these microspheres is important. This method could be the core principle 
running an “acoustic Coulter counter” instrument and used to test UCA filtrations before 
administration to patients. The next step envisioned is to analyze UCA populations in superficial arteries 
(e.g., carotid artery) because the method is noninvasive. Such an examination would give extra 
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information on the change in the size parameters that an UCA population experiences after patient 
administration and it would help designing microbubble size distributions dedicated to a given clinical 
application. However, to apply our sizing approach in vivo, some challenges will have to be overcome. 
Working at high frequencies limits the penetration depth because of tissue and blood attenuation. As a 
consequence, some bubbles may see their signals lost in the system noise. It is possible to use clinical 
scanners to image single bubbles as shown by Klibanov et al. [65]. This was achieved at lower frequencies, 
emitting at 1 MHz and receiving at 3 MHz. On the basis of our experimental results - pressure values of 
single Definity bubbles are >10 Pa - we believe that high-end scanners (signal-to-noise ratio <1 Pa) 
working at our frequency range should also be able to detect single bubbles. A single bubble flowing in 
the carotid artery (2.5 cm deep, 0.5 dB/cm/MHz attenuation) should give a response above the noise 
level if the incident pressure is increased to the MPa range (e.g., 4MPa) to compensate for attenuation. 
An absolute size distribution measurement in vivo would require the exact knowledge of the tissue 
attenuation.  However, even without that knowledge, a relative measurement of the standard deviation 
of a bubble population could be performed. Another issue is the calibration of the ultrasound beam and 
the possible presence of resonant bubbles depending on the frequency of the imaging modality (e.g., 15 
MHz for 3D carotid imaging). Moreover, the success of this technique depends on single bubbles passing 
through the focus one by one; otherwise, their size might be significantly underestimated. A solution 
would be to use two frequencies of the same transducer. To determine a bubble position with respect to 
the acoustic axis, two consecutive pulses of 20 and 30 MHz can be transmitted, taking advantage of the 
beam profile differences at both frequencies. A bubble is considered on axis when the difference in 
backscattered amplitudes at the two frequencies is minimal. The knowledge of the bubble positions, 
required to estimate their size acoustically, could be determined using a 3D probe. Although temperature 
elevation to 37°C and viscosity change in the bloodstream may affect the shell properties of UCAs, the 
acoustic sizing method presented here should still provide meaningful statistical results because it relies 
on the microspheres’ geometry. 
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3. 
 
IVUS Reconstruction of a 
Coronary Vasa Vasorum Model 
 
Based on the publication by D. Maresca, M. Emmer, G. Springeling, F. Mastik, G. van Soest, N. de Jong, A. 
F. van der Steen, Contrast-enhanced intravascular ultrasound 3D reconstruction of a vasa vasorum 
mimicking model. Ultrasonics Symposium (IUS), 2010 IEEE, pp. 2364-2367. 
 
ABSTRACT   
 
The development of newly formed microvessels within a coronary atherosclerotic plaque was associated 
with an increased risk of plaque rupture. To date, contrast-enhanced intravascular ultrasound (contrast 
IVUS) is the only technique that demonstrated potential for intracoronary vasa vasorum imaging in vivo. 
The present study aimed at evaluating the capacity of contrast IVUS to reconstruct in 3D a vasa vasorum 
model with a clinical IVUS catheter. We designed a polyvinyl alcohol based model, exhibiting a vasa 
vasorum mimicking branch pattern with cross sectional diameters ranging from 200 down to 100 μm. 
We perfused the vasa vasorum model with a commercial ultrasound contrast agent and performed a 
manual pullback that generated 93 IVUS images evenly spaced by steps of 200 µm. We segmented 
ultrasound contrast agent perfused areas in each IVUS image and successfully reconstructed in 3D the 
vasa vasorum model. We compared the segmented IVUS data with 10 μm thick microscopic slices of the 
vasa vasorum model at two co-registered pullback positions. The vasa vasorum mimicking micro channel 
diameters estimated with contrast IVUS agreed within 30 % with the microscopic slice diameters.  The 
feasibility of contrast IVUS imaging of vasa vasorum was demonstrated in vivo, and the technique might 
play a central role in vulnerable plaque detection. Fast in vivo pullbacks could be complementarily used to 
reconstruct vasa vasorum networks in three dimensions. 
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INTRODUCTION 
 
Major blood vessels such as the coronary arteries require their own blood supply. Blood is provided to the 
inner layers of the arterial wall by a network of microvessels referred to as the vasa vasorum (VV) [26]. 
The progression of atherosclerotic plaques is associated with the development of neovascular VV through 
the process of angiogenesis [7]. A first function of intra-plaque neovasculature is to sustain growth of the 
plaque beyond the diffusion limits of the existing blood supply. Neovascularization also fosters intra-
plaque inflammation, which is linked with plaque instability [66]. There is therefore clinical interest in 
investigating VV as a potential marker of plaque vulnerability. Studying coronary VV requires sensitive, 
robust and quantitative imaging techniques capable of detecting and spatially resolving small regions of 
vascularity and their location relative to the plaque structure (e.g. at base and ‘shoulders’ of lesions). The 
small vessel sizes, slow blood flow, and the presence of substantial coronary wall motion, pose 
considerable problems for imaging modalities to overcome. Currently, there is no established clinical 
technique capable imaging VV in the coronary arteries of humans. 3D micro-CT images of ex vivo 
coronary arteries have shown the role of angiogenic vasa vasorum (VV) in plaque growth and progression 
[28]. Goertz et al. [31] reported in vivo recordings of VV in a rabbit atherosclerotic aorta using contrast 
IVUS. Unfortunately, the results could not be compared to the exact microvasculature anatomy. 
To tackle this problem, several research groups developed capillary flow phantoms, notably to assess 
contrast agent replenishment kinetics [67]. The present work aimed at demonstrating the feasibility of a 
contrast IVUS reconstruction of a coronary vasa vasorum model in 3D, via a controlled phantom 
experiment. The goal of this study was double: first, evaluate qualitatively the capacity of contrast IVUS 
to reconstruct a simple vasa vasorum size microchannel pattern. Second, to assess the accuracy of the VV 
microchannel diameters reconstructed with contrast-enhanced IVUS imaging. 
 
METHODS 
 
Coronary artery vasa vasorum model | The use of tissue substitutes is an established method in 
ultrasound imaging [68]. In order to evaluate in a controlled manner the capacity of contrast-enhanced 
IVUS imaging to detect and reconstruct VV-like structures, we designed a coronary artery vasa vasorum 
model. The model exhibited a central channel with a constant luminal diameter of 3 mm that simulated a 
human coronary artery lumen. To simulate arterial wall microvasculature, we included a branching  
microchannel structure running parallel to the central channel at a distance of 1 mm. The microchannel 
diameter was equal to 200 μm before bifurcation and 100 μm after bifurcation. 
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 The phantom material was made of a 10% by weight solution of polyvinyl-alcohol (PVA) mixed with 
enamel paint droplets (1.0% by weight of the total solution) to increase scattering. The solution was 
frozen and thawed in three cycles of 2 hours at least to attaint acoustic properties similar to tissue [69]. 
We measured a speed of sound of 1511m/s at 25 MHz and an attenuation coefficient of 2.46 dB/mm at 
room temperature. Literature reports that coronary arteries show an approximate acoustic attenuation 
coefficient at 30 MHz of 2dB/mm [70]. A syringe connector was glued to the 200 μm entrance of the VV 
mimicking microchannel to enable perfusion of the model with an ultrasound contrast agent (Figure 1). 
 
 
 
Figure 1. Coronary artery vasa vasorum model. (a, b) PVA mold. A rigid metallic rod of 3 mm diameter was 
used to create the lumen. A 100 um metallic wire was winded up in a V pattern and fixed at the mold ends. 
The PVA solution was poured thereafter. (c) PVA model utilized for the pullback experiment. Reference 
needles were inserted perpendicular to the channels. An injection needle was glued at the entry of the 
microchannel, enabling perfusion of the ultrasound contrast agent. 
 
 
Contrast-Enhanced Intravascular Ultrasound | A clinical IVUS catheter (UltraCross 2.9 Coronary 
imaging catheter, Boston Scientific, Freemantle, USA) transmitted 30 MHz 80% bandwidth Gaussian 
modulated sine-bursts. We acquired 256 radio frequency (RF) lines per catheter rotation along a manual 
pullback consisting of 93 steps of 200 μm (Figure 2). The received RF data were bandpass filtered from 
18 to 43 MHz. The envelopes of the radiofrequency lines were computed, log compressed with a 
dynamic range ranging from 0 to 40 dB and scan converted. 
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Figure 2. (a) Contrast IVUS pullback setup. The IVUS 
catheter was inserted in the central lumen of the vasa 
vasorum model before to be pulled-back in a 
controlled manner using a precision stage after 
ultrasound contrast agent injection. (b) Schematic 
showing the principle for 3D vasa vasorum 
reconstruction. 2D IVUS images are acquired at evenly 
spaced pullback locations, enabling the detection of 
the central channel and VV-mimicking microchannel 
contours. 
 
 
As the commercial IVUS system utilized did not offer contrast mode capabilities, we perfused the VV 
mimicking channel with a native concentration of the ultrasound contrast agent DefinityTM (Lantheus 
Medical Imaging, MA, USA). Even in the absence of a contrast mode, we expected to detect in 
fundamental images the response of submicron DefinityTM bubbles that resonate at 30 MHz [40]. In 
order to evaluate the accuracy of contrast IVUS VV detection, we compared IVUS images at two 
registered locations with 10 μm thick microscopic slices of the VV model of the same locations. In the 
contrast IVUS images, the perfused VV contours were detected by applying a threshold in the intensity 
scale (set at 30dB). For reference, the lumen intensity, were no contrast agent was injected, was 3dB 
(Figure 3). 
 
 
 
Figure 3. 40 dB IVUS images at the second registered location were identified thanks the reference needle 
echo, which is visible at the bottom. Left, IVUS image before contrast injection. The 100 µm diameter vasa 
vasorum cross sections are invisible, below conventional IVUS resolution. Middle, IVUS image after 
ultrasound contrast agent injection. The vasa vasorum lumina are detected, appearing bright in the image. 
Right, zoom in IVUS image after thresholding at 30 dB, revealing the perfused microchannel areas only. 
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The model slices were imaged with a microscope (Visio 200, Tesa Technology, Renens, Switzerland) and 
the VV diameters were measured with the microscope software (Figure 4). 
 
 
 
Figure 4. Microscopic cross section at the two reference locations. The needle position is revealed by a 
hollow cavity perpendicular to the central lumen. Microchannel cross sections were identified and their 
dimensions estimated with the microscope software. 
 
3D reconstruction | All 93 pullback images processed with a 30 dB threshold to extract perfused 
microchannel areas. As consecutive contrast IVUS frames showed angular misalignment, a realignment 
scheme was applied. Angular variations between consecutive pullback frames were estimated by means of 
frame to frame subtraction. IVUS frame number i+1 is rotated along 360 degrees and iteratively 
subtracted to the previous IVUS pullback frame i. The minimum of the subtraction curves indicated the 
angular correction to apply to realign frame i+1 with frame i (Figure 5). After having realigned the 93 
contrast IVUS pullback frames, the 3D reconstruction of the vasa vasorum model was performed by 
meshing the 30 dB iso-surfaces corresponding to the ultrasound contrast agent filled microchannel areas. 
The 3D volume obtained was smoothed using a Gaussian filter. All processing steps were performed 
using Matlab. 
 
 
 
 
 
 
 
 
Figure 5. Correction of the frame to frame 
angular variations. Frame i+1 is rotated along 
360 degrees and iteratively subtracted to 
reference frame i. The minimum of the 
subtraction curve indicates the correction 
angle. In this example, the correction angle 
was -61 degrees. 
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RESULTS 
 
The phantom microchannel was successfully perfused and the ultrasound contrast agent Definity TM 
could be detected in all 30 MHz IVUS images despite the lack of a contrast mode. The VV mimicking 
channel diameters were estimated at the two needle locations (Figure 1). Microscope measurements of 
the model slices provided microchannel diameter values of 201 µm at location 1 (before bifurcation), and 
151 µm and 127 µm at location 2 (after bifurcation). In the corresponding contrast IVUS image the 
microchannel perfused area corresponded to 35 pixels at location 1, leading to a diameter estimation of 
208 µm in good agreement with the microscope measurement. At location 2, we counted 25 pixels for 
both microchannel perfused areas, corresponding to a diameter of 176 µm (Figure 3), showing a lesser 
agreement with the microscope measurement. Pixel counts to diameter conversions were achieved under 
the assumption that detected pixel areas were circular. Knowing the pixel resolution (1 pixel length 
equaled 31.25 µm), we estimated microchannel diameters. 
We successfully reconstructed the VV mimicking model in three dimensions (Figure 6). The single 
channel design followed by a bifurcation is clearly discernible. The registration of IVUS images locations 
allowed the combined visualization of the coronary model morphology and the 3D microvasculature 
structure. 
 
 
 
 
 
 
Figure 6. 3D reconstruction of the 
vasa vasorum model superimposed 
with three IVUS pullback frames. 
The branching structure of the vasa 
vasorum model was clearly 
identified. 
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DISCUSSION 
 
We have shown that contrast-enhanced intravascular ultrasound enabled the 3D reconstruction of a 
controlled microvasculature structure embedded in a coronary artery model. VV networks are invisible in 
conventional in vivo IVUS imaging but we showed that structures of similar dimensions could be 
reconstructed using contrast IVUS. The axial resolution of our 30MHz clinical catheter (measured on a 
sub-wavelength 30 µm thick tungsten wire) was 133 µm. Consequently, the 100 µm channels of the vasa 
vasorum model lay below the system’s resolution. The use of contrast IVUS made their detection 
possible but their diameters were nonetheless overestimated. 
The PVA coronary artery model designed proved to be a successful substitute for a controlled contrast 
IVUS experiment. The lumen and the vasa vasorum mimicking microchannel were molded using a 
metallic rod and two interleaved metallic wires that were pulled back from the model once it reached 
proper acoustic properties. This procedure prevented the use of artificial capillaries, which present 
unrealistic acoustic properties at IVUS frequency. 
The irregularities in the 3D volume obtained are thought to be caused by the distribution of the contrast 
agent, the surface roughness following the wire extraction and the discrepancy between axial and lateral 
IVUS resolution. Refined contour detection techniques (e.g. steepest intensity gradient detection in the 
area of interest) could be used to improve the contour detection of contrast filled areas. 
The experiment was performed with a conventional catheter used in the clinical practice and a commercial 
ultrasound contrast agent. If the result is encouraging, it also highlighted important hurdles for vasa 
vasorum imaging using clinical IVUS systems. The clinical translation of 3D vasa vasorum imaging will 
require further developments in contrast IVUS imaging. The non-diluted ultrasound contrast agent dose 
used in this study is not compatible with medical guidelines. Therefore, the development of sensitive IVUS 
contrast imaging techniques and their implementation on existing catheters is necessary. Harmonic 
techniques such as second harmonic and subharmonic IVUS imaging were successfully tested [71] but since 
they require ultra-wideband IVUS transducers, feasibility relied on prototype IVUS transducers that are 
not commercially produced [72]. Novel bandwidth-limited contrast IVUS methods are therefore desirable 
to transfer IVUS vasa vasorum imaging into clinical practice. Nevertheless, as IVUS imaging can be carried 
out in vivo, contrast IVUS could play a critical role in percutaneous coronary interventions or clinical trials 
in helping identifying vulnerable coronary plaques. 
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4. 
 
Intravascular Ultrasound 
Chirp Imaging 
 
Based on the publication by D. Maresca, K. Jansen, G. Renaud, G. Van Soest, X. Li, Q. Zhou, N. De Jong, 
K. K. Shung, A. F. W. Van Der Steen, Intravascular Ultrasound Chirp Imaging. Appl. Phys. Lett. 100,  
(2012). 
 
ABSTRACT 
 
We demonstrate the feasibility of intravascular ultrasound chirp imaging as well as chirp reversal 
ultrasound contrast imaging at intravascular ultrasound frequency. Chirp excitations were emitted with a 
34 MHz single crystal intravascular transducer and compared to conventional Gaussian-shaped pulses of 
equal acoustic pressure. The signal to noise ratio of the chirp images was increased by up to 9 dB relative 
to the conventional images. Imaging of contrast microbubbles was implemented by chirp reversal, 
achieving a contrast to tissue ratio of 12 dB. The method shows potential for intravascular imaging of 
structures in and beyond coronary atherosclerotic plaques including the vasa vasorum. 
 
INTRODUCTION 
 
Atherosclerosis is a chronic systemic disease of the arterial wall and a leading cause of premature death 
worldwide. Most cardiac adverse events result from the rupture of a vulnerable atherosclerotic plaque and 
subsequent thrombosis in the coronary vascular tree [7]. It is recognized that the formation of new 
microvessels in the arterial wall is critical to the progression of plaques due to red blood cell leakage and 
constitutes an important marker of plaque vulnerability [73]. These networks of microvessels, ranging in 
diameter from 200 µm down to 5 µm, are referred to as vasa vasorum (VV). 
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As of today, clinically available tools are unable to detect coronary artery VV. Goertz et al. [31] 
demonstrated the feasibility of VV imaging in a rabbit aorta, using intravascular ultrasound (IVUS) in 
combination with an experimental micron sized ultrasound contrast agent (UCA). By exciting UCA-
specific nonlinear resonances with IVUS pulses, contrast infused areas can be disentangled from tissue 
signals. This method allowed for the detection of arterial wall microvasculature lying below the 
resolution limit of conventional IVUS. Unfortunately, these results were achieved with a prototype dual 
frequency IVUS transducer and are not implementable on existing clinical IVUS systems due to 
frequency bandwidth limitations. 
In this Letter, we develop chirp IVUS, with the dual objective of extending the viewing depth, and 
implementing chirp reversal contrast imaging in a manner that is applicable on a conventional 
bandwidth-limited IVUS transducer. At a given mechanical index (MI) and frequency bandwidth, chirp 
excitations can be used to carry more energy than conventional short imaging pulses. The higher energy 
converts into a higher signal to noise ratio in medical ultrasound images and permits the visualization of 
deeper structures in the body. Furthermore, specific chirp compression processing can be used to retrieve 
a good imaging resolution. To date, ultrasound chirp imaging was implemented in noninvasive clinical 
imaging only [74]. 
Chirps are also beneficial for UCA detection purposes, as the transient resonant response of 
microbubbles close to resonance differs for insonification with up and down frequency sweeps [75, 76]. 
Capitalizing on this asymmetry, we present a contrast imaging mode that provides good contrast to tissue 
ratio (CTR) at clinically approved concentrations of UCA. 
The first part of this study, we investigated the performance of IVUS chirp imaging on several phantoms, 
as well as an atherosclerotic human coronary artery ex vivo. In the second part, we evaluated chirp reversal 
contrast IVUS imaging using a channel phantom perfused with a commercial UCA. 
 
B-mode IVUS imaging | The experimental intravascular imaging system consisted of a 
mechanically rotated single element IVUS transducer (single-crystal lead magnesium niobate-lead 
titanate; PMN-PT [77], active surface 0.5 x 0.5 mm2, center frequency 34 MHz, -6 dB bandwidth 
60%, 2 mm natural focus) mounted in a catheter assembly with a 0.9 mm outer diameter. A 
photograph of the transducer is shown in Figure 1. 
 
 
Figure 1. 0.5 x 0.5 mm IVUS 
transducer mounted in a 0.9 
mm diameter rigid catheter 
assembly. (Left) zoom on the 
square transducer surface. 
(Right) Experimental IVUS probe. 
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We transmitted interleaved Gaussian envelope sine wave pulses and chirp excitations of equal peak 
negative pressure using an arbitrary waveform generator (Tabor Electronics WW2571A) at 1° angular 
position steps using a motorized rotary stage (Steinmeyer GmbH). The Gaussian modulated pulses were 
emitted at the transducer center frequency with a 60% -6 dB bandwidth. The chirp excitations chirp(t) 
were formulated as chirp(t)=a(t)cos(2πφ(t)), where a(t) is the envelope and φ(t) the phase. In order to 
minimize the side lobe level after chirp compression, we selected a quasi-linear phase φ(t), defined in 
relation to the instantaneous frequency fi(t) as 
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where f1 is the initial chirp frequency, f2 the final chirp frequency and T the signal duration. All chirp 
excitations were apodized using an 11% tapered Tukey window. The ultrasound radio-frequency (RF) 
data was digitized at 350 MHz (Acqiris DP-310) and band-pass filtered. The received chirp RF lines 
were compressed by cross-correlation with the emitted chirp signal. The chirp envelope after 
compression was simulated and compared to the Gaussian sine-wave pulse envelope for our set of 
transmission parameters (Figure 2).  
 
 
 
 
 
 
 
Figure 2. Simulation of the chirp 
envelope after compression in 
comparison with the Gaussian pulse 
envelope 
 
 
The narrowing of the main lobe which is observed translates into an improved in axial resolution. 
Simultaneously, sidelobes appear at a level of -23 dB. The short pulse at the transducer center frequency is 
still providing the highest resolution. Experimentally, the axial resolution and signal to noise ratio (SNR) 
were determined from the echoes of 15 μm thick platinum/iridium wires at distances of 1.5, 3, 5 and 7 mm 
from the probe, mounted in a hollow cylinder. Additionally, a cylindrical agar-based phantom [78], with a 
lumen of 3 mm diameter and three parallel 2 mm channels at distances of 3, 5, and 7 mm off-axis, was 
designed in order to assess tissue penetration depth. Intravascular ultrasound chirp imaging of human 
coronary atherosclerosis was performed ex vivo. The artery was provided by the Pathology Department of 
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the Erasmus Medical Center according to local Medical Ethics Committee regulations. The tissue was snap 
frozen at -80°C within an hour after autopsy. Before imaging, the specimen was thawed in phosphate 
buffered saline (PBS), mounted in a PBS filled tank and pressurized to 100 mmHg to keep the lumen open. 
The chirp excitations used for the wire phantom measurement had a temporal length of 0.3 μs, a frequency 
sweep ranging from 25 to 42.5 MHz and an MI of 0.19 (Figure 3). 
 
 
 
Figure 3. Gaussian modulated sine wave (top) fc = 34 MHz, -6 dB bandwidth 60% and chirp coded 
excitation (bottom), 25 to 42.5 MHz sweep, 11% tapered Tukey window, pulse length = 0.3 µs. The chirp 
instantaneous frequency sweep is plotted in red. 
 
Using chirps, we measured a gain in SNR of 8 dB for the closest wire and 9 dB for the other three 
compared to the conventional imaging pulse. The axial resolution (-6 dB point spread function) at the 
wire closest to the focus was 106 μm for the pulse and 153 μm for the chirp excitation after compression 
while the lateral resolution was 272 μm for both. The sidelobe level in the compressed chirp image was at 
-23 dB relative to the main lobe (Figure 4).   
 
 
 
 
Figure 4. Subwavelength wire phantom imaged 
using pulses (a) and chirps (b). The dynamic range 
is 55 dB. The scalebar represents 1 mm. (c) 
Comparative performance of conventional IVUS 
versus chirp IVUS. 
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Chirp imaging was applied to the tissue-mimicking phantom, and compared to the pulse image, as 
displayed in Figures 5a and 5b. The third side channel appears at 8 o’clock in the chirp image only. Based 
on the SNR gain of 8 dB, an imaging depth extension of 1.9 mm, from 5.6 mm to 7.4 mm was achieved. 
With the ex vivo human coronary artery, a gain in SNR of 7 dB was measured in the chirp image 
compared to the pulse image (Figure 5c, d). 
 
  
 
Figure 5. (a) Channel phantom image using pulses and chirps (b). The dynamic range is 55 dB. (c) Human 
coronary artery image using pulses and chirps (d). The dynamic range is 48 dB. The scalebar corresponds 
to 1 mm. (e) Histology at corresponding location. 
 
CONTRAST-ENHANCED IVUS IMAGING 
 
Chirp based contrast imaging was evaluated for its potential to detect VV. The UCA used was Definity® 
(Lantheus Medical Imaging, North Billerica, MA). We first simulated the pressure scattered by a 1 μm 
diameter bubble in response to an up and down sweep chirp (duration 0.5 μs, frequency sweep 22 to 46 
MHz, MI 0.19) with a visco-elastic shell model using the UCA high frequency shell parameters as 
described by de Jong [79]. Next, for the experiment, the UCA was activated and decanted for 15 to 30 
minutes to extract the smallest contrast bubbles which resonate at IVUS frequencies. With this method, 
the mean bubble diameter was less than 2 μm [40]. Finally, a 1:1000 dilution was prepared. Chirp 
reversal contrast measurements were performed by filling the lumen and the first two channels of the 
tissue mimicking phantom with the UCA while the third one was filled with water. A two step pulsing 
scheme excited the UCA, first with a down sweep chirp and then with an up sweep chirp transmitted at 
10 μs intervals. 
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The simulation results clearly show the asymmetry between the bubble echoes of a down and up sweep 
chirp (Figure 6c and 6d). A one micron diameter UCA bubble resonates at 25 MHz [40]. The bubble 
response is enhanced when the driving frequency is close to its resonance frequency, which happens at 
the beginning for the up sweep chirp and at the end for the down sweep chirp. In addition, a ringdown 
effect elongates the bubble response to the down sweep chirp compared to the driving excitation. 
Therefore, the subtraction of the compressed bubble echoes gives a residual contrast signal. 
Experimentally, the chirp reversal contrast image had a CTR of 12 dB (ratio of mean bubble and tissue 
signal amplitudes) achieved at clinically approved concentration of this UCA (Figure 6f). Bubbles could 
be detected up to a depth of 5 mm. 
 
 
 
 
Figure 6. Simulated incident down (a) and up sweep (b) chirps sent a micron size UCA bubble and 
corresponding scattered acoustic pressures (c, d). (e) Down sweep chirp image and (f) contrast image of the 
channel phantom perfused with the UCA. The dynamic range is 54 dB for the left image and 21 dB for the 
contrast image. 
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DISCUSSION 
 
These results demonstrate the feasibility of intravascular ultrasound chirp imaging of human coronary 
atherosclerosis at intravascular ultrasound frequencies. A significant SNR gain was achieved, leading to 
an extension of signal penetration of 1.9 mm, at some cost in axial resolution and limited appearance of 
side lobes. High-frequency chirp reversal contrast imaging was achieved. This IVUS contrast mode has 
the potential to image VV in a clinical setting, using commercially available UCAs in a low dose. Reliable 
in vivo quantification of VV holds promise for plaque vulnerability imaging. 
The gain in SNR for coded excitations is equal to the time-bandwidth product, and as a result, chirp 
imaging benefits from long pulses. The duration of chirp excitations in IVUS is limited, however, because 
image targets are immediately adjacent to the transducer (Figure 5b, c). Theoretically, the SNR can be 
further enhanced, and the sidelobe level can be reduced, using mismatched filtering [80]. IVUS is the 
clinical standard to assess the geometry and size of coronary plaques in vivo. Image interpretation and 
segmentation, often ambiguous tasks for trained evaluators at present, may benefit from the SNR gain, 
allowing for sharper contour detection.  
Chirp IVUS will complement conventional IVUS methods by providing extended imaging depth, 
allowing for imaging deep into and beyond the plaque. Using chirp reversal, it adds a promising method 
for contrast-enhanced IVUS, imaging plaque vulnerability by quantifying plaque microvessels with low 
dose clinically approved UCAs, and with conventional frequency-band limited IVUS catheters. 
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5. 
 
Contrast-Enhanced Intravascular 
Ultrasound Pulse Sequences for 
Bandwidth-Limited Transducers 
 
Based on the publication by D. Maresca, G. Renaud, G. van Soest, X. Li, Q. Zhou, K. K. Shung, N. de Jong, 
A. F. W. van der Steen, Contrast-Enhanced Intravascular Ultrasound Pulse Sequences for Bandwidth-
Limited Transducers. Ultrasound in Medicine & Biology 39, 706-713 (2013). 
 
ABSTRACT  
 
We demonstrate two methods for vasa vasorum imaging using contrast-enhanced intravascular 
ultrasound, which can be performed using commercial catheters. Plaque neovascularization was 
recognized as an independent marker of coronary artery plaque vulnerability. IVUS-based methods to 
image the microvessels available to date require high bandwidth (26 dB relative frequency bandwidth 
>70%), which are not routinely available commercially. We explored the potential of ultraharmonic 
imaging and chirp reversal imaging for vasa vasorum imaging. In vitro recordings were performed on a 
tissue-mimicking phantom using a commercial ultrasound contrast agent and a transducer with a center 
frequency of 34 MHz and a -6 dB relative bandwidth of 56%. Acoustic peak pressures, 500 kPa were 
used. A tissue-mimicking phantom with channels down to 200 μm in diameter was successfully imaged 
by the two contrast detection sequences while the smallest channel stayed invisible in conventional 
intravascular ultrasound images. Ultraharmonic imaging provided the best contrast agent detection. 
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INTRODUCTION 
 
The identification of vulnerable coronary atherosclerotic plaques remains a central issue in cardiac 
imaging [81]. As with malignant tumors, intraplaque formation of new microvessels is critical to the 
progression of atherosclerosis and may constitute an independent marker of vulnerability [3, 66], a 
hypothesis recently supported by a 3D micro-computed tomographic study of ex vivo coronary arteries 
[28]. There is a clear role in both studies of atherosclerosis and diagnostic imaging for methods capable of 
detecting and visualizing the microvascular networks within the arterial wall, also referred to as ‘‘vasa 
vasorum’’ (VV). VV diameters reported in human diseased arteries range from 2–200 μm [82]; however, 
the clinical tools to image coronary artery VV in vivo do not exist. Intravascular ultrasound (IVUS) is an 
established minimally invasive diagnostic tool that provides high-resolution intravascular images of the 
vessel wall and atherosclerotic plaques [83, 84]. It has been shown that IVUS combined with an 
ultrasound contrast agent (UCA) has the capacity to detect VV in the arterial wall [31, 32, 85]. Pulse 
inversion schemes proved to be efficient in cancelling fundamental signals and therefore detecting 
subharmonic or second harmonic responses from UCAs [37, 71]. In a step toward harmonic IVUS 
imaging of VV, an IVUS transducer having two frequency peaks at 22 and 40 MHz was designed [31, 32, 
86, 87]. Despite a good sensitivity, this transducer suffered from a lower spatial resolution than 
conventional clinical IVUS because of the narrow bandwidth of the two frequency peaks (two-way 30%, 
-6 dB relative bandwidth) and is not produced commercially. Alternatively, harmonic IVUS imaging 
could be performed with single-frequency peak IVUS transducers presenting a -6 dB relative frequency 
bandwidth of 70% or more [72]. Such a frequency bandwidth allows one to transmit at the inferior or 
superior limit of the -6 dB frequency bandwidth and receive the response of UCA at the second 
harmonic frequency or the subharmonic frequency with adequate sensitivity. These broadband IVUS 
transducers have not progressed beyond the prototype stage to date, and they remain far from application 
in routine clinical devices. In this study, we investigated the performance of two contrast-enhanced 
intravascular ultrasound pulse sequences for VVimaging functioning with conventional IVUS transducer 
bandwidths (<60%), chirp reversal IVUS imaging [44] and ultraharmonic IVUS imaging. Chirp reversal 
capitalizes on the asymmetric resonant response of UCAs to upsweep and downsweep chirp excitations. 
Ultraharmonic imaging presents two advantages over subharmonic imaging. First, a 40% -6 dB relative 
bandwidth is sufficient to capture it, whereas the second harmonic or subharmonic require 70%. In 
addition, the lateral resolution of ultraharmonic imaging is expected to be superior to subharmonic and 
fundamental imaging [88]. Like the subharmonic response, the ultraharmonic response is a UCA-
specific response that is not generated by tissue, thus providing a contrast signal more specific than 
second harmonic imaging [89-91]. Both IVUS contrast detection methods were evaluated in a tissue-
mimicking phantom including channels perfused with a commercial ultrasound contrast agent. 
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MATERIALS AND METHODS 
 
Tissue mimicking phantom for IVUS vasa vasorum imaging | To mimic a coronary artery cross 
section with intra-wall vascularization, we manufactured a tissue mimicking phantom [68] with five 
through cavities; a central lumen 3 mm in diameter and four side channels of diameters equal to 2 mm, 1 
mm, 500 μm and 200 μm. Human VV vessel diameters, which range from a few hundred micrometers 
down to a single red blood cell dimension [82], were simulated in our phantom by the 200 μm channel. 
All side channels were situated at a distance of 500 μm from the central lumen border, and the total 
phantom diameter was equal to 2 cm (Fig. 1). The phantom material was made of 10% w/w polyvinyl 
alcohol gel mixed with 0.5% w/w silicon carbide particles less than 15 μm in size (SiC, K-800, MTN-
Giethoorn) and 0.5% w/w silicon dioxide particles ranging 1–5 μm to account for scattering and 
attenuation. The mixture underwent three freeze thaw cycles to reach tissue mimicking mechanical 
properties (Hansen et al. 2010). 
 
 
 
 
Figure 1. Channel phantom mimicking 
arterial wall vasculature. The 200 mm 
diameter vasa vasorum mimicking channel is 
visible below the central lumen. The phantom 
diameter is 2 cm. 
 
 
 
IVUS imaging system overview | The IVUS imaging system used in this study was similar to the one 
described in Maresca et al. [44]. A mechanically rotated unfocused single element IVUS transducer 
(PMN-PT single-crystal, 0.5 x 0.5 mm2, center frequency 34 MHz, -6 dB frequency bandwidth of 56% 
ranging 24–44 MHz) was mounted in a catheter assembly with an outer diameter of 0.9 mm [77]. The 
flat transducer had a natural focus distance of 2 mm and a lateral resolution of 270 μm at focus [44]. A 
schematic of the circuit is depicted in Figure 2. Interleaved sequences of excitations were transmitted 
using an arbitrary waveform generator (model WW2571A; Tabor Electronics, Tel Hanan, Israel) with 
angular steps of 1 degree. The received ultrasound radiofrequency data were amplified by 43 dB (Miteq 
AU1263), digitized at a sampling frequency of 350 MHz with a 12 bit dynamic range (DP310; Acqiris, 
Geneva, Switzerland), digitally filtered and scan converted. No power amplifier or filters were used in the 
circuit in order to minimize waveform distortion. 
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Figure 2. Overview of the intravascular ultrasound (IVUS) imaging system. 
 
 
Contrast agent handling for IVUS | We used the commercial UCA Definity (Lantheus Medical 
Imaging, North Billerica, MA, USA). It essentially contains microbubbles with a diameter between 1.1 
and 3.3 μm with 98% of the bubble population <10 μm according to the manufacturer’s specifications. 
Micrometer-sized bubbles that resonate at IVUS frequency (20–50MHz) were selected by means of 
decantation as described by Goertz et al. [32]. A vial of the commercial UCA Definity was decanted 
for 1 h. 0.2 mL of UCA was extracted, diluted in 200 mL of degassed water (dilution ratio 1:1000, of 
the order of dilution ratios administered for human use; Giannoni et al. [93]) and stirred with a 
magnetic stirrer for 30 seconds. This protocol ensured an average resonance frequency of the prepared 
UCA close to 20 MHz and therefore suited for IVUS imaging. A tank containing the tissue mimicking 
phantom was filled with the UCA solution, ensuring that a uniform concentration of UCA was 
expected in the lumen and in the side channels. The UCA suspension remained static (no flow) during 
image acquisition. 
 
IVUS pulse-inversion ultraharmonic sequence | The transmission of pairs of phase-inverted 
excitations, referred to as pulse inversion [37], is a powerful technique to selectively detect the 
nonlinear response of UCAs [94]. To test ultraharmonic IVUS imaging, we transmitted sequences of 
inverted Gaussian modulated sine bursts with a center frequency of 22 MHz, fractional bandwidth of 
50%, duration of 0.2 μs and peak negative pressure of 500 kPa (Fig. 3a, 3b). The pressure level was 
chosen to limit tissue harmonics generation [71] and ensure a minimal destruction of the UCA. The 
harmonic content of received radiofrequency lines was extracted by summing consecutive inverted 
pulses and digital filtering from 30–50 MHz to extract the ultraharmonic and second harmonic 
components. 
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IVUS chirp reversal sequence | Chirp reversal [44, 75, 95] is a specific contrast detection method 
relying on the resonant behavior of microbubbles. The transient resonant response of a bubble close to 
resonance to up and down frequency sweeps differs, whereas the response conserves the waveform of 
the excitation in a non-resonant medium, such as tissue at low acoustic pressures. Novell at al. [75] 
reported that chirp reversal was most efficient for a transmitting frequency above the resonance 
frequency of the interrogated bubble. The IVUS chirp reversal imaging sequence was made of chirp-
coded excitations centered at 35 MHz (20–50 MHz linear frequency sweep, duration of 0.42 μs, peak 
negative pressure of 300 kPa, Tukey windowed with a 90% taper ratio) as shown in Figure 4. The peak 
negative pressure was chosen to minimize artifacts generated by nonlinear propagation, visible at 
higher pressures [44]. Pairs of upsweep and downsweep chirps were subsequently transmitted at 1 
degree angular position steps. The received ultrasound data were digitally filtered (20–50 MHz) and 
compressed by cross correlation with the chirp excitation signal (matched filtering) as reported by 
Maresca et al. [44]. Transmitted excitations do not have the same temporal length in both pulse 
sequences. Chirp excitations were designed (duration, bandwidth and envelope) to obtain, after 
compression, an axial resolution equal to that of the pulse inversion excitations. 
 
 
 
 
Figure 3. Needle hydrophone measurements. (a, b) Phase-inverted excitations of the ultraharmonic 
sequence. (c) Envelope of an excitation of the ultraharmonic sequence, (d) frequency spectra of the 
excitations of the ultraharmonic sequence and (e) residual signal after addition of the inverted excitations of 
the ultraharmonic sequence. 
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RESULTS 
 
Hydrophone characterization of axial resolution and tissue cancellation | To characterize the 
imaging performance of both IVUS contrast imaging pulse sequences, the transmitted waveforms were 
recorded in water at the transducer focus using a calibrated hydrophone (75 μm polyvinylidene fluoride 
needle hydrophone; Precision Acoustics Ltd., Dorchester, Dorset, UK) and corrected for frequency 
dependent hydrophone sensitivity (Figs. 3a, 3b, 4a, 4b). The axial resolution (full width at half 
maximum) of the pulse inversion waveforms (ultraharmonic imaging) was 122 μm for the input 
excitation and 171 μm experimentally (Fig. 3c), computed with the average speed of sound in tissue 
(1540 m/s). The axial resolution of the compressed chirp signals (chirp reversal imaging) was 122 μm 
theoretically and 144 μm experimentally (Fig. 4c). The experimental waveforms of the ultraharmonic 
pulse inversion sequence overlapped accurately in the frequency domain (Fig. 3d). In the time domain, 
their summation gave a residual signal of relatively small amplitude (20% of the experimental waveform 
amplitude at focus) that corresponds to the second harmonic component generated by nonlinear 
propagation in water (Fig. 3e). The experimental chirp reversal waveforms (Fig. 4a, 4b) were not fully 
symmetrical in terms of envelope, and their frequency spectra did not overlap perfectly in the 40–50-
MHz range (Fig. 4d) because of the transducer response. However, the compressed chirp signals 
overlapped in the time domain with a limited mismatch, and their subtraction gave a residual signal of 
small amplitude (16% of the compressed chirp amplitude; Fig. 4e). In practice, the residual signals in 
contrast modes are expected to be smaller in tissue than in water. Nonlinear propagation creates part of 
the residual signal because it distorts the waveform. The higher attenuation in tissue reduces nonlinearity 
compared to water. 
 
 
 
 
 
Figure 4.  
Needle hydrophone 
measurements:(a, b) Upsweep and 
downsweep chirps of the chirp 
reversal sequence. (c) Compressed 
chirp envelope, (d) frequency 
spectra of the chirp excitations and 
(e) compressed excitations and 
their residue after subtraction. 
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Detection of tissue-mimicking phantom side channels | IVUS contrast imaging results are presented 
in Figure 5. B-mode images are displayed with a 40 dB dynamic range. For both B-mode and contrast 
mode images, the 0 dB level is defined by the maximum amplitude in the B-mode. For both contrast-
imaging sequences, the three largest phantom side channels were resolved in the absence of UCA, 
whereas the smallest VV mimicking channel was not visible (Fig. 5a, 5d). After UCA injection, all 
channels had tissue level echogenicity, and were therefore undetectable with conventional B-mode 
imaging (Fig. 5b, 5e). In both contrast modes (Fig. 5c, 5f), the central channel and the four side channels 
were detected above residual tissue signal level. The smallest VV mimicking channel was at the edge of 
detection with the chirp reversal sequence, but well resolved with the ultraharmonic pulse inversion 
sequence. Contrast images (Fig. 5c, 5f) were further characterized in terms of contrast-to-noise ratio 
(CNR), measured as the ratio of the maximum intensity in a contrast-filled region of interest over the 
maximum noise intensity, and contrast-to-tissue ratio (CTR), defined as the ratio of the maximum 
contrast intensity over adjacent maximum residual tissue intensity at equal depth. Results per phantom 
channel were computed for three datasets and are presented in Figure 6. As expected from chirp 
processing, the CNR of chirp reversal imaging proved to be superior for all channels (up to 20 dB for the 
2 mm channel), whereas the CTR proved to be superior for the three largest channels (up to 9.8 dB for 
the 2 mm channel) than in the pulse-inversion ultraharmonic sequence. The VV mimicking channel was 
detected more clearly in the ultraharmonic contrast image that featured a larger echogenic area 
corresponding to the 200 μm channel as well as a higher CTR (10.6 dB) compared with the chirp reversal 
image. Despite the lower peak negative pressure, residual tissue-to-noise ratio was 20% higher for chirp 
reversal imaging (Fig. 5c) than for ultraharmonic imaging (Fig. 5f). CTR is critical for the detection of 
sub-resolution targets, such as VV, which can be easily misinterpreted from a tissue residual signal. Our 
results indicate that ultraharmonic IVUS is more robust for VV detection. Subharmonic contrast 
imaging was also evaluated by transmitting a 0.35 μs, Gaussian-modulated sine-burst with a center 
frequency of 45 MHz and with a peak negative pressure of 560 kPa (maximum pressure output of our 
system at 45 MHz). The subharmonic component was extracted using pulse inversion (Goertz et al. 
2006b). A maximum CTR value of 7 dB was found for the 2 mm channel. 
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Figure 5. Images acquired in the tissue-mimicking phantom using the chirp reversal sequence and the 
pulse inversion sequence. (a) IVUS chirp image without contrast. (b) IVUS chirp image with contrast. (c) 
IVUS chirp reversal contrast image. (d) 22 MHz conventional IVUS image without contrast. (e) 22 MHz 
conventional IVUS image with contrast. (f) Ultraharmonic IVUS contrast image. Intensity scales in contrast 
 
Ultraharmonic contrast IVUS | The analysis of the frequency content of the pulse inversion contrast 
image (Fig. 5f) revealed that most of the UCA signal came from the ultraharmonic frequency band rather 
than from the second harmonic band (Fig. 7b, 7c). This finding is understandable because the sensitivity 
of the transducer at the second harmonic frequency is low. The amplitude of the 200 μm channel was 
indeed 4.2 dB higher in the contrast image filtered in the ultraharmonic band (Fig. 7b) than in the image 
filtered in the second harmonic band (Fig. 7c). To illustrate the nonlinear components extracted by the 
pulse inversion sequence, we simulated the pressure backscattered by a single Definity bubble (diameter 
= 1 μm; viscosity κs = 4.2 x 10-10; shell elasticity χ = 0.75 N/m; low initial surface tension σ[R0] = 0.0015 
N/m) in response to the experimental pair of phase-inverted IVUS excitations [62]. Figure 7a presents 
the pulse inversion spectrum of the single bubble response. While the fundamental frequency peak is 
suppressed, the subharmonic, ultraharmonic and second harmonic components are observed. Knowing 
the transducer -6 dB frequency bandwidth (Fig. 7a), the transmitted pulse frequency was chosen to 
generate a UCA ultraharmonic response at the maximum transducer sensitivity (34 MHz). The 
simulation also indicated that at high frequency, the amplitude of the ultraharmonic response of a single 
UCA microbubble can be of the same order as the amplitude of the subharmonic response. Although the 
second harmonic component showed the highest peak in the simulated pulse-inversion spectrum, its 
frequency lay outside the transducer bandwidth of -6 dB. The second harmonic component therefore 
had a lower amplitude (Fig. 7c). 
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DISCUSSION 
 
Ability to detect a vasa vasorum sized channel | Ultraharmonic IVUS contrast imaging enabled the 
detection of a 200 μm diameter channel invisible in conventional IVUS images, allowing for functional 
imaging of sub-resolution microvascular structures such as VV. The capacity of ultraharmonic IVUS 
contrast imaging to detect the smallest phantom channel proved to be superior to that of chirp reversal 
IVUS contrast imaging. This may be due to the higher susceptibility of chirp reversal to nonlinear 
propagation artifacts, to the effects of frequency dependent attenuation on chirp waveforms and to the 
transducer response. For all these reasons, chirp reversal IVUS is likely to be less robust than a pulse 
inversion sequence when it comes to imaging microvascular networks. We observed that the B-mode 
chirp image (Fig. 5a) provided a better spatial resolution than the B-mode image of the ultraharmonic 
pulse inversion sequence (Fig. 5d). Although the input excitations had a similar axial resolution (Figs. 3c, 
4c), hydrophone measurements showed a superior axial resolution in chirp IVUS (144 vs. 171 μm). As 
the 22 MHz input excitation was outside the transducer bandwidth of -6 dB, its transmission resulted in 
an elongated waveform because of longer transducer ringdown. In addition, the lateral resolution in the 
B-mode chirp image (34 MHz center frequency) is finer than in the pulse-inversion B-mode image (22 
MHz center frequency). Nonetheless the 200 μm channel was undetected in both B-mode images 
because its diameter was below the lateral resolution of the transducer, equal to 270 μm at the center 
frequency [44]. An adequate comparison between the contrast imaging methods we propose in this 
study, and subharmonic imaging, would require higher transmitting pressure to attain sufficient 
subharmonic generation. This higher pressure can be generated only if a power amplifier were to be 
included in the transmit circuit. Because short transmission pulses and minimal dead time after 
transmission are key in these experiments, which use short ranging depths and small targets, fast gating of 
such an amplifier is essential. We had no access to a suitable instrument, and as a result were not able to 
perform this experiment. For this reason, we cannot truly rank chirp reversal, ultraharmonic and 
subharmonic imaging in terms of contrast detection capability. The scarcity, cost and bulk of suitable 
power amplifiers, which have sufficient harmonic suppression, places subharmonic imaging at a 
disadvantage for practical implementation. 
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Figure 6. Contrast to tissue ratio (CTR) and contrast to noise ratio (CNR) per phantom channel of the two 
IVUS contrast imaging modes presented. 
 
Future developments in harmonic contrast IVUS imaging | To achieve a higher B-mode resolution, a 
short pulse at the transducer center frequency could be transmitted in addition to the two pulses 
dedicated to ultraharmonic imaging. If broadband IVUS transducers become available in the future, new 
possibilities would emerge for IVUS contrast imaging. With a transducer bandwidth of 70% (frequency 
bandwidth at half maximum), a pulse inversion sequence would be able to detect the ultraharmonic and 
the second harmonic responses of contrast microbubbles. However, such an approach would suffer from 
the generation of a second harmonic component by tissue and artifacts owing to the distortion of 
transmitted waveforms because of nonlinear propagation in contrast agent [89, 91]. With a 100% 
transducer bandwidth, a contrast mode combining the subharmonic and the ultraharmonic signals could 
be implemented. Contrary to the second harmonic component, these signals are only produced by UCA 
microbubbles. A gain in CTR of 6 dB can be expected compared with ultraharmonic imaging only, 
because the backscattered pressures at the subharmonic and ultraharmonic frequencies can have similar 
amplitudes (Fig. 7a). 
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Figure 7. (a) Simulated pulse inversion backscattered pressure of a micrometer-sized Definifty bubble. (b) 
Pulse-inversion contrast image filtered in the ultraharmonic band (31–44 MHz) and (c) filtered in the second 
harmonic band (44–52 MHz). 
 
 
CONCLUSION 
 
Chirp reversal IVUS emerged from our experiments as a balanced two-pulse technique that performs 
well both in terms of B-mode imaging and contrast detection of targets within the system resolution, but 
could not detect the vasa vasorum sized channel. The ultraharmonic IVUS pulse sequence presented does 
not require any additional hardware implementation (contrary to chirp excitations) and could therefore 
be readily applied on existing commercial IVUS scanners in in vivo applications. Between the two 
methods investigated in this study, we recommend ultraharmonic imaging as the best method for IVUS 
imaging of vasa vasorum because it enabled the detection of a 200 μm channel. 
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6. 
 
Imaging Microvasculature with 
Contrast-Enhanced 
Ultraharmonic Ultrasound 
 
Based on the manuscript by D. Maresca, I. Skachkov, G. Renaud, K. Jansen, G. van Soest, N. de Jong, A. 
F. W. van der Steen, Imaging Microvasculature with Contrast-Enhanced Ultraharmonic Ultrasound. 
Submitted. 
 
ABSTRACT  
 
Atherosclerotic plaque neovascularization was shown to be one of the strongest predictors of future 
cardiovascular events. Yet, the clinical tools for coronary wall microvasculature detection in vivo are 
lacking. Here we report an ultrasound pulse sequence capable of detecting microvasculature invisible in 
conventional intracoronary imaging. The method combines intravascular ultrasound with an ultrasound 
contrast agent, e.g. a suspension of microscopic vascular acoustic resonators that are small enough to 
penetrate the capillary bed after intravenous administration. The pulse sequence relies on brief chirp 
excitations to extract ultrasound contrast agent specific ultraharmonic echoes. We implemented the 
pulse sequence on an intravascular ultrasound probe and successfully imaged the microvasculature of a 6 
days old chicken embryo respiratory organ. The feasibility of microvasculature imaging with intravascular 
ultrasound sets the stage for a translation of the method to studies of intraplaque neovascularization 
detection in humans. 
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INTRODUCTION 
 
The progression of human coronary atherosclerosis is associated with increased arterial wall 
microvasculature density [28, 66]. This network of microvasculature, the vasa vasorum, originates from 
the adventitial layer of large blood vessels to supply the deeper media and intima layers with nutrients 
and oxygen [26]. In atherosclerotic arteries, erratic vasa vasorum neovascularization can occur (fig. S1), 
leading to intra-plaque hemorrhage and ultimately plaque rupture [3, 96]. It is hypothesized that 
atherosclerotic plaque neovascularization density could serve as surrogate marker of plaque vulnerability 
[3]. However, existing clinical tools are unable to detect coronary vasa vasorum in vivo. Intravascular 
ultrasound (IVUS) in combination with an ultrasound contrast agent has demonstrated potential for 
vasa vasorum imaging [31, 32] but fails to reach clinical practice to date due to IVUS transducer 
limitations in frequency bandwidth and sensitivity [97]. To overcome these limitations, we developed 
ultraharmonic IVUS imaging, a narrow frequency bandwidth contrast detection method able to visualize 
sub-resolution microvascular networks without the blood flow velocity limitations of Doppler 
ultrasound [98]. 
Ultrasound contrast agents are suspensions of high molecular weight gas microbubbles encapsulated by 
thin lipid shells [94]. Bubbles are typically designed to be of a size (1-10 μm) that passes through capillary 
beds and are acoustically active at diagnostic ultrasound frequencies. The primary advantages of using 
ultrasound contrast agents are the improvement of the signal strength from blood, which becomes bright 
in echographic images (a parallel can be drawn with bright blood pulse sequences in magnetic resonance 
imaging), and the detection of slow microvascular flow in the presence of tissue motion [99]. Contrast 
ultrasound imaging techniques rely upon the stimulation of resonant microbubble behaviours to 
generate and detect harmonic ultrasound contrast agents’ backscattered signals [94] that differ from 
tissue backscattered signals. Current harmonic contrast ultrasound imaging methods are limited to 
second harmonic (echo at twice the transmit frequency) or subharmonic (echo at half the transmit 
frequency) imaging. However, second harmonic echoes are not ultrasound contrast agent specific, while 
the use of subharmonic echoes lowers image resolution [88]. Furthermore, detecting second or 
subharmonic echoes demands a transducer frequency bandwidth of 67% which exceeds clinical IVUS 
transducers specifications [97]. Several contrast echocardiography studies relied on second order 
ultraharmonics at 2.5 times the transmit frequency [100, 101]. But this strategy requires very wideband 
systems (86% frequency bandwidth) and sensitive detection of these low amplitude harmonics is further 
limited by the frequency-dependent ultrasound attenuation in cardiac tissue (0.5 dB/cm/MHz). 
Our approach consisted in imaging contrast microbubbles using the first order ultraharmonics that arise 
at 1.5 times the transmit frequency [94]. These signals are specific to ultrasound contrast agents and their 
proximity to the transmit frequency makes their capture possible with a transducer frequency bandwidth  
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of 40% (Materials and Methods). Hence, ultraharmonic imaging allows for the emission and reception of 
ultrasound pulses within the sensitive frequency range of commercially available IVUS transducers. 
Furthermore, relying on contrast-specific ultraharmonic echoes prevents misclassifying tissue artefacts as 
microbubbles [89], as in the case of second harmonic imaging. For a given probe having a given 
bandwidth, it also provides an enhanced lateral image resolution compared to subharmonic imaging [88]. 
In practice, the ultrasound echoes backscattered by ultrasound contrast agents are dominated by signal at 
the transmit frequency. In order to isolate contrast agent ultraharmonics, we transmitted pairs of phase 
inverted chirp excitations, summed the backscattered echoes and filtered the residual signal in the 
ultraharmonic frequency range (see Material & Methods). This approach, known as pulse-inversion [37], 
suppresses transmit frequency signals while preserving most of harmonic signals. 
 
 
RESULTS 
 
Contrast agent ultraharmonic echoes locate microchannels below IVUS resolution | We first 
evaluated the ultraharmonic IVUS pulse-inversion sequence by simulating [62] the scattering response of 
a single contrast microbubble to a pair of phase inverted chirp excitations. Transmitted IVUS chirp 
excitations had a 23 to 29 MHz frequency sweep, corresponding to a center frequency f0 equal to 26 
MHz. The frequency response of the single microbubble after summing the pair phase-inverted 
backscattered echoes is reported (Fig. 1). The simulation result illustrates that the spectrum amplitude at 
the transmit frequency (f0 = 26MHz) and its odd multiples (third harmonic at 3f0 = 78 MHz) are 
significantly suppressed whereas even harmonics (second harmonic at 2f0 = 52 MHz) and 
ultraharmonics (1.5f0 = 39MHz, 2.5f0 = 65MHz) are successfully extracted. As expected, the simulation 
also shows that the first ultraharmonic (1.5f0) has a higher amplitude than subsequent ultraharmonics 
(2.5f0, 3.5f0). Note that ultrasound attenuation in cardiac tissue, not taken into account in the simulation 
(Fig. 1), further increases this amplitude difference since the first ultraharmonic is less attenuated that 
the 2nd ultraharmonic. 
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Figure 5. Principle of the intravascular ultrasound pulse sequence. Pairs of phase inverted pulses noted p1 
and p2 are transmitted by the IVUS transducer (called a pulse-inversion sequence). Corresponding 
backscattered echoes e1 and e2 are received by the transducer. If the insonified medium is linear (biological 
tissue) echoes stay symmetric and their sum is zero. If the medium is nonlinear (ultrasound contrast agent) 
echoes are distorted and their sum leaves a residue. The residual frequency spectrum of a single contrast 
microbubble was simulated with the Marmottant model [62] (1.3 µm diameter that resonates at 26 MHz, 
viscosity κs = 4.2.10-10, shell elasticity χ = 0.75 N/m, initial surface tension σ(R0) = 0.006 N/m). A range of 
harmonics are visible at multiples of the transmit IVUS frequency (26 MHz), including the first 
ultraharmonic response at 39 MHz, whereas the transmit frequency peak is efficiently suppressed by the 
pulse inversion sequence. The waveforms utilized in the simulation are displayed in fig. S6. 
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Experimentally, we first investigated the performance of ultraharmonic contrast IVUS in vitro by 
imaging a custom coronary vasa vasorum phantom with our laboratory IVUS imaging system (Material 
and Methods, Fig. 2A). To ensure that phantom measurements are predictive of the performance of 
ultraharmonic IVUS in perivascular coronary tissue, we selected a tissue mimicking material [102] that 
realistically renders ultrasound properties in biological tissue (speed of sound, attenuation) at our 
frequency range (20-50MHz). Therefore, tissue cancellation levels observed in the phantom experiment 
with the pulse inversion sequence are good predictors of the in vivo situation. We first insonified the 
coronary artery vasa vasorum phantom with conventional 35 MHz IVUS pulses in the absence of 
ultrasound contrast agent. As anticipated, the lumen contour and the 500 μm side channels were 
detected while the 200 μm channels, smaller than IVUS lateral resolution [4], remained undetected (Fig. 
2B). Next, we immersed the coronary vasa vasorum phantom in a static ultrasound contrast agent 
suspension, using a realistic in vivo dilution (106 microbubbles per mL). The acoustic pressure 
transmitted (of the order of 600 kPa at focus in tissue) is considered non-destructive for contrast 
microbubbles at IVUS frequency. This time, the phantom was insonified with the IVUS pulse sequence, 
consisting in pairs of chirp excitations with a center frequency of 26 MHz. As a result, the lumen and side 
channels echogenicity rose to tissue level, making the channels invisible in the conventional IVUS image 
(Fig. 2C). Application of the ultraharmonic signal processing revealed all side channels, including the 
200 μm sub-resolution channels (Fig. 2D). We measured the intensity of the side channels in terms of 
contrast-to-tissue ratios. Values reached a maximum of 9.8 dB at a distance of 2.8 mm before decreasing 
to 2.9 dB at 3.8 mm (Fig. 2E), following conventional unfocused transducer beam characteristics [103]. 
Note that in the presence of a contrast filled lumen, which is a more attenuating medium than blood, the 
ultraharmonic ultrasound imaging method detected microchannels up to a distance of 4.3 mm from the 
transducer. This range is well adapted to the detection of intraplaque coronary neovascularture in 
humans. The results also demonstrate that it is possible to perform ultraharmonic ultrasound imaging at 
IVUS frequency using the native size distribution of a commercial ultrasound contrast agent. In light of 
these results, we subsequently performed an in vivo investigation of the ultraharmonic IVUS imaging. 
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Figure 6. In vitro evaluation of ultraharmonic IVUS imaging. (A) Schematic setup depicting the IVUS probe actuated by the rotary 
stage, the arbitrary wave generator transmitting the pulse-sequence and the digitizer for data acquisition. (B) 35 MHz 
conventional IVUS image of the coronary vasa vasorum phantom; only the 500 μm side channels were detected. Scalebars in IVUS 
images represent 1 mm. (C) Conventional 26 MHz IVUS image in the presence of an ultrasound contrast agent. The lumen and 
side channels became echogenic and could not be distinguished from the phantom material.  (D) Ultraharmonic IVUS image. The 
lumen and all the side channels filled with the ultrasound contrast agent were detected, including the 200 μm sub-resolution 
channels. On the contrary, tissue signals were suppressed below noise level. (E) Contrast to tissue ratio of the 500 μm and 200 
μm channels. The contrast to tissue ratio reached a maximum at 2.8 mm. Note that the distances of the 500 μm and 200 μm 
channels to the probe are shifted because the IVUS probe was not at the center of the lumen. (F) Schematic cross section of the 
coronary vasa vasorum phantom channels. The lumen diameter is 4 mm. 
 
Ultraharmonic IVUS imaging reveals an embryonic respiratory vascular plexus | We translated the 
experiment in vivo to establish the capacity of ultraharmonic IVUS to image intricate microvasculature 
of vasa vasorum dimension. We selected a chicken embryo model as it enabled the optical registration of 
the insonified vascular geometry, contrary to former intravascular in vivo studies [31, 32]. By day 6, 
chicken embryos have developed a respiratory and waste elimination organ called the allantois. This 
organ appears as an extra-embryonic hollow sphere delineated by a thin membrane. The allantois 
membrane itself is webbed with a dense network of microvessels exhibiting cross sections (diameters < 
200 μm) of the order of human atherosclerotic plaque vasa vasorum [82]. We positioned the IVUS probe 
next to the allantois membrane for insonification (fig. S2, Fig. 3B). We first acquired a 35 MHz 
conventional IVUS image as well as an ultraharmonic IVUS image of the allantois membrane before 
administration of the ultrasound contrast agent (Fig. 3A). The allantoic membrane appears in the 
bottom left quadrant of the conventional IVUS image. Due to the membrane intrinsic echogenicity, the 
dense allantois microvasculature is not resolved in the image. The echogenic structures on the right hand  
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side of the conventional IVUS image correspond to the yolk. In the ultraharmonic image, the 
echogenicity of the allantois membrane and the yolk is suppressed to noise level by the pulse inversion 
sequence. Next, a 4 μL bolus of ultrasound contrast agent was administered in the vitelline vein of the 
chicken embryo using a capillary glass injection needle. We acquired a set of conventional and 
ultraharmonic IVUS images of the allantois membrane at the same location with two minutes intervals 
(Fig. 3A). The spread of the ultrasound contrast agent though the allantois microvasculature was clearly 
visible in the set of ultraharmonic images, indicating that hemodynamics can be tracked. Note that an 
enhancement of the microvessels infused with contrast is also visible in the conventional IVUS images. 
By subtracting the pulse-inversion frequency spectra of the allantois membrane before and after contrast 
administration, we observed experimentally the appearance of an ultraharmonic frequency peak induced 
by the ultrasound contrast agent generation in response to the pulse-inversion sequence (Fig. 3C). 
 
 
 
Figure 7. In vivo evaluation of ultraharmonic IVUS imaging. (A) Conventional 35 MHz IVUS and co-registered 
ultraharmonic IVUS imaging of the ultrasound contrast agent spreading in the allantois membrane of 
a 6 days old chicken embryo. Before injection, the allantois membrane appears echogenic in conventional 
IVUS but its microvasculature is not resolved. In the corresponding ultraharmonic IVUS image,  
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intrinsic tissue echogenicity is suppressed to noise level and the image appears black in the absence of 
contrast. After ultrasound contrast agent administration, ultraharmonics reveal the membrane perfusion 
over time. Microvascular structures clearly emerge after 6 minutes. Note that the conventional IVUS images 
are also enhanced but one cannot disentangle microvessel echogenicity from the intrinsic membrane 
echogenicity. Scalebars in IVUS images represent 1mm. (B) Schematic of the setup. A bolus of contrast is 
injected using a capillary glass needle. The IVUS probe is positioned perpendicular to the allantois 
membrane for insonification. (C) In vivo pulse-inversion frequency spectra before (black line) and after (blue 
line) contrast injection. Their subtraction (red line) reveals the ultraharmonic intensity backscattered by the 
ultrasound contrast agent. Frequency spectra were computed in the yellow outline depicted in Fig (3A). 
 
 
Complementary to these in-plane contrast dynamic observations, we performed an in-depth scan of 
the allantois membrane. Conventional IVUS images at 35 MHz and ultraharmonic IVUS images 
were acquired at five equidistant positions in depth, covering in total a distance of 800 μm (Fig. 4A). 
Microvessels infused with contrast appear in the ultraharmonic IVUS images, as seen at the 0 mm 
and -0.2 mm positions (Fig. 4A). We computed a mean intensity projection of the five planes imaged 
with both the conventional and ultraharmonic IVUS (Fig. 4B). In the conventional IVUS image, the 
presence of microvessels can be suspected thanks to the enhanced echogenicity induced by the 
ultrasound contrast agent. However, based on echogenicity levels alone, it is not possible to 
disentangle the contrast-enhanced microvessels from the intrinsic echogenicity of the allantoic 
membrane. On the contrary, as the ultraharmonic IVUS image displays only the microvasculature 
filled with contrast agents, the allantois vascular plexus appears with a superior contrast. 
Quantitatively, the contrast to tissue ratio between a microvessel and the adjacent membrane was up 
to doubled (12.5dB in ultraharmonic IVUS image as opposed to 6 dB in the conventional IVUS 
image). For reference, a photograph of the allantois microvasculature insonified with the IVUS 
probe was taken and corroborated the ultraharmonic ultrasound result with a strong agreement (Fig. 
4C). Note that the photograph also displays deeper vessels that were outside of the volume 
insonified with IVUS. 
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Figure 8. In vivo ultraharmonic IVUS scan across the allantois membrane microvasculature. (A) 
Conventional and ultraharmonic IVUS imaging at 5 different depths, equally spaced by 200 microns. 
Positions in mm are labeled yellow. (B) Corresponding mean intensity projections. The ultraharmonic IVUS 
image reveals the allantois microvasculature. (C) Zoom in the membrane microvasculature imaged with 
ultraharmonic IVUS and comparison to a photograph of same the region of interest. Arrows indicate 
corresponding vessels in the two images. Scalebars in IVUS images represent 1 mm. 
 
This final result demonstrates the capacity of ultraharmonic IVUS to image a dense network of vasa 
vasorum sized vessels that would have been invisible in the absence of an ultrasound contrast agent (as in 
the conventional IVUS image before contrast injection in Fig. 3A). 
 
DISCUSSION  
 
Intraplaque vasa vasorum density was shown to be one of the strongest predictors of atherosclerotic 
plaques at risk that require intervention [3]. Yet, there are no clinical tools at present for coronary vasa 
vasorum detection in vivo. Our results demonstrate that the implementation of an ultrasound contrast 
agent detection pulse sequence enhances the physiological contrast of IVUS by enabling the detection of 
intricate vasa vasorum sized targets. Our strategy consisted in sensing contrast agent specific echoes at 1.5 
times the transmit frequency, referred to as ultraharmonics. The in vivo echolocation of ultraharmonics 
with an IVUS probe revealed microvasculature infused with ultrasound contrast agents (Fig. 3 and Fig. 
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4). The limited frequency bandwidth requirement of ultraharmonic ultrasound imaging made its 
implementation on a conventional IVUS transducer possible, contrary to other existing harmonic 
methods. We also show that one can augment the ultraharmonic response of an ultrasound contrast 
agent by relying on chirp excitations rather than conventional imaging pulses (fig. S6). 
To date, ultraharmonic ultrasound imaging has received little attention in the field of medical 
ultrasound, probably because the amplitude of ultraharmonics is usually lower than the amplitude of 
subharmonics. Yet, the ability to transmit and receive ultrasound pulses within the bandwidth of 
commercially available transducers is a major advantage for imaging as it improves sensitivity [97] 
(Materials and Methods). We also report in the phantom experiment that despite its high frequency 
range, ultraharmonic IVUS could be performed without manipulating the size distribution of a 
commercial ultrasound contrast agent. Finally, contrary to ultrasound Doppler techniques for blood flow 
imaging, contrast-enhanced IVUS is not impaired tissue motion [99]. In light of these results, the next 
step will consist in performing intracoronary ultraharmonic IVUS imaging in a porcine model of 
atherosclerosis. A limitation of the method is that, despite its enhanced microvasculature detection 
capabilities compared to conventional IVUS, image resolution itself is not improved. A subresolution 
microvessel filled with contrast will still appear as big as the imaging system’s point spread function. This 
can be observed in Figure 4C. Accurate volumetric quantification of microvasculature relies on imaging 
resolution and remains a future target. Meanwhile, ultraharmonic IVUS fulfills its primary role of 
providing a metric of microvascular density in the coronary artery wall by successfully detecting small 
blood vessels. 
The dose of ultrasound contrast agent injected in the phantom experiment was in line with current 
medical guidelines. In the embryo case it was one order of magnitude higher (107 bubbles per mL). 
Guidelines must be defined for contrast IVUS investigations in larger animal models of atherosclerosis 
and eventually in humans. From the point of view of imaging, it is critical that enough ultrasound 
contrast agents reach the vasa vasorum. As the vasa vasorum is mostly perfused from the outside-in, 
through the external venous network, rather than from the artery lumen [26], bolus injections of 
contrast will need to be performed upstream from the site of interest. Studies need to be conducted to 
establish optimal ultrasound contrast guidelines for contrast IVUS investigations of coronary arteries. 
Note that we do not anticipate motion artifacts in ultraharmonic IVUS images. 20 μs are required to 
transmit and receive a pair of phase inverted excitations in order to scan a depth of 8 mm. Lateral motion 
of the artery wall reaches peak velocity of a few cm/s. The effect of this motion within 20 μs is negligible. 
Analogous to the development of MRI blood detection sequences, IVUS will widen its scope by adopting 
blood detection pulse sequences like ultraharmonic ultrasound imaging. Ultraharmonic IVUS could not 
only help identifying vulnerable plaques requiring intervention but also be play a role in the follow-up of 
cardiac patients. The resurgence of atherosclerosis at stented sites is a growing concern in interventional 
cardiology and became a target for novel intravascular imaging techniques [104]. Here again, the vasa 
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vasorum could be a valuable early risk predictor. Beyond the scope of IVUS, ultraharmonic ultrasound 
imaging can be implemented on any conventional ultrasound scanner to study inflammatory processes of 
clinical importance, such as atherosclerosis, rheumatoid arthritis or cancer development. 
 
MATERIALS AND METHODS 
Frequency bandwidth of harmonic contrast ultrasound imaging methods | The frequency 
bandwidth BW required for harmonic contrast ultrasound imaging is defined as the difference between 
the transmit ultrasound pulse frequency fT and its harmonic echo frequency fH over the center frequency 
fc = (fT + fH)/2,  
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For second harmonic (fH=2fT) and subharmonic imaging (fH=fT/2), the frequency bandwidth 
requirement is BW=2/3 or 67%. For ultraharmonic imaging (fH=3fT/2), the frequency bandwidth 
requirement is BW=2/5 or 40%. The feasibility of a given harmonic contrast ultrasound imaging method 
depends on the frequency bandwidth of the ultrasound imaging probe utilized. 
 
Laboratory intravascular ultrasound imaging system | We conducted this study with a miniaturized 
unfocused IVUS transducer [77] (34 MHz center frequency, 56% frequency bandwidth) assembled into 
a side-looking IVUS probe and actuated with a rotary stage (Steinmeyer DT105). The transmission 
circuit of the IVUS imaging system comprised an arbitrary waveform generator (Tabor Electronics 
WW2571A), a custom-made expander and the IVUS probe. The receive circuit consisted of a custom-
made limiter, a 43 dB low noise amplifier (Miteq AU1263) and a 12 bit digitizer (Acqiris DP310) (fig. 
S3). The imaging system functioned as follows: short ultrasound pulses were coded and transmitted as 
16V peak-peak electric signals by the arbitrary waveform generator. The expander stopped low voltage 
noise while letting the pulses go to the transducer. The transducer converted electric pulses into 
ultrasonic pressure pulses that propagated in the medium of interest. Ultrasound echoes backscattered in 
the medium hit the transducer surface back where they were continuously converted into an electric 
radiofrequency (RF) signal. The limiter let the low amplitude RF signal go to the low noise amplifier, 
while blocking the 16V pulses transmitted by the waveform generator. After amplification, the received 
RF signals were digitized and saved in a computer. The pulse/delay generator synchronized all 
instruments. We performed cross-sectional scans by rotating the IVUS probe in 1° steps using a 
motorized rotary stage. Each IVUS image consisted of 360 evenly spaced pulse-echo radiofrequency lines 
digitized at a sampling frequency of 350 MHz. Conventional IVUS imaging (Fig. 2b) was achieved by 
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transmitting 35 MHz 60% bandwidth Gaussian envelope sine wave pulses. These full-band pulses 
transmitted at the transducer center frequency provide the highest resolution attainable with our IVUS 
system (axial resolution = 106 μm, lateral resolution = 272 μm). They were used to assess the micro 
channels detection capabilities of conventional IVUS imaging. 
 
Ultraharmonic intravascular ultrasound pulse sequence | The ultraharmonic pulse-inversion 
sequence investigated in vitro and in vivo consisted of 3 pairs of phase inverted [37] chirp excitations (23 
to 29 MHz linear frequency sweep, 0.3 μs duration, 880 kPa peak negative pressure at focus in water, 
Tukey windowed with a 100% taper ratio) transmitted at each angular step. We extracted the 
ultraharmonic content of the digitized radiofrequency lines by summing the echoes received in response 
to the pairs of inverted excitations and digitally filtering the summed radiofrequency data from 33 MHz 
to 47 MHz. Frequency values were selected to operate in the most sensitive region of the IVUS 
transducer bandwidth (fig. S4). Chirp excitations proved to enhance the ultraharmonic response of 
microbubble contrast agents by 2 dB compared to sine-bursts of identical center frequency, envelope and 
peak negative pressure (fig. S5). The simulation of the pulse-inversion response of a single contrast agent 
[62] supported this observation (fig. S6). 
 
Coronary vasa vasorum phantom | The agar-based tissue mimicking material was characterized in the 
10-47 MHz frequency range [102], covering our IVUS application. This ensured acoustic properties 
(speed of sound and attenuation) similar to those of human biological tissue. A schematic cross section of 
the phantom geometry is provided (Fig. 2F). 
 
Chicken embryo model | A chicken embryo model was used for in vivo validation of the ultraharmonic 
ultrasound method. By day 6, chicken embryos have developed a respiratory and waste elimination organ 
called the allantois. This organ appears as an extra-embryonic hollow sphere delineated by a thin 
membrane. The allantois membrane itself is webbed with a dense network of microvessels exhibiting 
cross sections (diameters < 200 μm) of the order of human atherosclerotic plaque vasa vasorum [82]. 
Fertilized White Leghorn chicken eggs (Gallus gallus domesticus) were purchased from a local supplier 
(Drost BV). After 6 days of incubation at 37°C in a humidified incubator (Thermo Scientific) 
corresponding to stage HH27-29 according to the Hamburger and Hamilton criteria [105], the embryos 
were taken out of the eggshell and placed into the experimental setup (fig. S2). The optical reference 
measurements of the allantoic microvasculature imaged with IVUS were calibrated with a millimetric 
scale. Microvessel cross sections were measured in terms of pixel lengths using the ImageJ software and 
converted into metric units thereafter. 
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Ultrasound contrast agent handling | We used the commercial ultrasound contrast agent DefinityTM 
(Lantheus Medical Imaging). This contrast agent contains mostly microbubbles of diameters ranging 
from 1.1 and 3.3 μm, with 98% of the bubble population below 10 μm. Since a 1 μm diameter single 
DefinityTM bubble resonates at 25 MHz [40], it is the micron to submicron sized bubbles that contribute 
mostly to the harmonic signal at IVUS frequencies. In the phantom experiment, we activated the 
ultrasound contrast agent according to manufacturer’s recommendations (45 seconds controlled 
shaking) and diluted it in degassed water with a dilution ratio of 1:1000, which of the order of dilutions 
administered in human use [106]. Subsequently, the phantom was immersed in a tank containing the 
prepared contrast agent solution. 
In the in vivo experiment, we first performed a 10 minutes decantation of the contrast agent DefinityTM 
after activation and subsequently extracted the bottom 0.2 mL to preferentially retain small contrast 
microbubbles active at our frequency range [97]. We administered a 4 ± 1 µL undiluted bolus of the 
ultrasound contrast agent in one of the vitelline veins of the chicken embryo using a home-made capillary 
glass needle and a commercial injection system (VisualSonics). This in vivo dose was shown to work in a 
previous chicken embryo study [107]. Due to the addition of the decantation step, however, the 
volumetric concentration of contrast microbubbles that we administered in vivo was lower [40]. 
 
Acknowledgments | We thank K. Shung and Q. Zhou (University of Southern California) for 
providing the IVUS transducer. This research was supported by the Dutch Technology Foundation 
STW (2007 Simon Stevin Meester grant). 
 
 
SUPPLEMENTARY MATERIALS 
 
 
 
 
Supplementary Figure 1. Schematic cross 
section of a vulnerable atherosclerotic 
plaque, illustrating an outside-in 
proliferation of the vasa vasorum into the 
atherosclerotic lesion. Other makers of 
atherosclerotic plaque vulnerability are 
represented e.g. large necrotic core, thin 
fibrous cap, calcification and macrophage 
infiltration. 
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Supplementary Figure 2. Photograph of the 6 days 
old chicken embryo during ultraharmonic contrast 
IVUS scanning. The IVUS probe was positioned next 
to the allantois membrane, which developed above 
the embryo. The bolus of ultrasound contrast agent 
was administered using an injection needle via the 
vitelline veins, upstream from the heart. 
 
 
 
 
 
 
 
 
Supplementary Figure 3. Configuration of the 
laboratory intravascular ultrasound electronic 
circuit. 
 
 
 
 
 
 
 
Supplementary Figure 4. 
Characterization of the IVUS 
transducer with a needle hydrophone 
(Precision acoustics). (Top) Time 
impulse response recorded at the 
natural focus of the transducer (2 mm). 
(Bottom) Frequency spectrum of the 
impulse response. The measured center 
frequency (red dot) and bandwidth 
(dotted lines) were in close agreement 
with the documented values (center 
frequency of 34 MHz, frequency 
bandwidth <60%). 
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Supplementary Figure 5. 
Comparison of the contrast to 
tissue ratio (CTR) per 
phantom microchannel (Fig. 
2) of the ultrasound contrast 
agent in response to the sine-
burst and chirp 
ultraharmonic pulse-inversion 
sequence. The CTR 
performance of the chirps was 
superior at every depth. 
 
 
 
 
 
 
 
Supplementary Figure 6. The response of a single DefinityTM contrast microbubble to the sine-burst 
ultraharmonic pulse-inversion sequence (Left column) and chirp ultraharmonic pulse-inversion sequence 
(Right column) was simulated using the Marmottant model (17) (diameter 1.3 µm, viscosity κs = 4.2.10-10, 
shell elasticity χ = 0.75 N/m, initial surface tension σ(R0) = 0.006 N/m). The transmitted phase inverted 
waveforms are plotted in red and blue (Top row). The frequency spectra of the waveforms scattered by a 
single bubble were modeled and are displayed in red and blue (Middle row). The scattered pulse-inversion 
spectra are plotted in black (Bottom row). The model predicted a 2.3 dB increase of the ultraharmonic 
amplitude with the use of chirps compared to sine-bursts. 
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Based on the manuscript by D. Maresca, S. Adams, B. Maresca, A. F. W van der Steen, Lessons learned 
through a Sociological Study of IVUS Innovation. Submitted 
 
INTRODUCTION 
 
Tremendous advances occurred during the last 40 years in the field of medical imaging of the heart and 
the coronary vasculature, triggered by the increasing need to reduce acute myocardial infarctions. The 
intravascular imaging route led to the development of X-ray angiography in the 1960’s, balloon 
angioplasty and related techniques in the late 1970’s and early 1980’s. Meanwhile, in the early 1970’s, 
academic research programs focused on developing two-dimensional real-time ultrasound imaging of the 
heart, transferring in particular underwater acoustics knowledge to medicine. This noninvasive route let 
to echocardiography, an imaging modality acclaimed for its radiation free nature but lacking the 
resolution to image the coronary vasculature. 
 
The need for a technique able to provide high resolution images of diseased coronary artery wall 
structures, referred to as vulnerable plaques [6, 7] and primarily responsible for myocardial infarctions, 
arose in the early 1990’s when false-negative coronary angiography cases became evident [13]. 
Intravascular ultrasound (IVUS) is a catheter-based echocardiography modality that was patented in 
1972 [16] and further developed to investigate the status of the coronary artery wall. IVUS catheters are 
side looking devices that generate circular cross sectional images of the arterial wall, perpendicular to the 
longitudinal artery axis. The tip of an IVUS catheter incorporates either a single piezoelectric transducer 
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(40 to 60 MHz frequency range) or a circular array of transducers (20 MHz). Single transducer IVUS 
images are acquired by mechanically rotating the transducer over 360 degrees, while in circular array 
IVUS the ultrasound beam is steered electronically. The resolution of IVUS images is of the order of 100 
μm in the axial direction, 300 μm in the lateral direction [44], and IVUS imaging depth typically ranges 
from 5 to 10 mm. IVUS technology has played an important role in the standardization of balloon 
angioplasty and stent treatments. Before intervention, IVUS can provide the artery lumen diameter, the 
plaque morphology and burden [18] thanks to the delineation of the external elastic membrane, and can 
be used to select optimal stent dimensions. Post intervention, IVUS is also useful to control stent 
apposition and possible complications. In addition, IVUS technology proved to be very useful in 
cardiovascular research. Since plaque progression and regression can be accurately measured with IVUS, 
the efficacy of new cardiovascular therapies on plaque volume can be quantified. IVUS also serves as gold 
standard for the evaluation of new intravascular modalities. Next to the estimation of plaque burden, the 
most valued IVUS function is calcium detection. Yet, to predict the risk for future acute cardiovascular 
events, the knowledge of plaque composition, which is not provided by conventional IVUS, is critical 
[20]. To that end, several IVUS signal processing techniques have been developed to augment IVUS 
capabilities in detecting and characterizing coronary artery plaques at risk. 
 
Looking back, the realization of IVUS is undoubtedly a technical success. Twenty years after its 
introduction in the clinic in the early 1990’s, IVUS technology continues to bring scientific insight into 
the pathophysiology of the coronary artery disease and helps guiding percutaneous coronary 
interventions. To date, noninvasive imaging techniques capable of identifying coronary artery wall 
lesions comprise magnetic resonance imaging (MRI) and multi-slice computed tomography (MSCT), 
but their resolution remains inferior to in situ catheter techniques. Minimally invasive techniques 
include coronary angiography, angioscopy, IVUS, intravascular optical coherence tomography (OCT), 
the combination of near infrared reflectance spectroscopy (NIRS) with IVUS and fractional flow reserve 
(FFR). OCT in particular has emerged as a rival for IVUS by generating more superficial but higher 
resolution images of the arterial wall. 
 
Since its introduction in the clinic, however, IVUS innovation appears relatively limited, especially in 
terms of image quality. Significant academic innovations such as IVUS flow [22], IVUS palpography 
[24] or harmonic IVUS [108] were not transferred to market by industry. Furthermore, IVUS remains a 
niche technology, whose clinical practice did not vastly expand nor disappear. Looking at IVUS 
reimbursement worldwide, which varies considerably, gives insight in how IVUS is accepted. Japan, for 
example, reimburses IVUS separately, even for a diagnostic use, whereas in the United States, IVUS is 
not separately reimbursed but specific procedure codes do leave enough room for IVUS utilization where 
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necessary. In the rest of the world, there is no separate reimbursement for IVUS. Market penetration 
follows accordingly. 
 
In this paper, we explored the current adoption and the future perspective for IVUS technology in light 
of sociology of innovation. By mapping IVUS controversies conveyed by international experts in the field 
together with the dynamics of their professional interaction, we sharpen our understanding of the IVUS 
status quo. 
 
METHODS 
 
To outline the dynamics of the actor-network [109] that generates IVUS innovations and uses IVUS 
technologies, we conducted a questionnaire-based survey [110] of biomedical experts with experience in 
the technology and practice of IVUS. To that end, we selected a deliberative sample of respondents: a 
representative group of 49 experts dealing with the question of IVUS innovation or adjacent fields. 
Potential respondents were identified through publications in the field and confirmed through an expert 
check (Professor van der Steen, head of the Biomedical Engineering Department of the Thorax Centre, 
Erasmus University Medical Center, the Netherlands). Identified actors comprised interventional 
cardiologists, academic and corporate engineers, corporate leaders and public and private funders. 
 
Survey design | We developed a questionnaire on IVUS innovation and refined it through face-to-face 
interviews with three actors. After revision, the questionnaire was issued to all other actors (the final 
questionnaire is annexed to the present manuscript). The questionnaire started with two open questions 
about coronary atherosclerosis diagnostic in humans: “What is the best method available to diagnose 
human coronary atherosclerosis?”, and “What would be an ideal technique to diagnose coronary arteries?”. 
The first question permitted to review the coronary diagnostic tools that are currently appraised. The 
second question aimed at highlighting the limitations of existing diagnostic tools and identifying future 
diagnostic solutions with strong potential in the respondents’ opinion. The questionnaire followed with 
questions centered on IVUS. To characterize the homogeneity of the respondents, we asked them to rate 
(from 0 - not so much, to 10 - extensive) their technical, clinical and market knowledge representation of 
IVUS. We collected their opinions on the advantages and drawbacks of IVUS. Next came two central 
questions: the room IVUS technology has left for improvement (to be rated from 0 - no room, to 10 - 
lots of room), and the likelihood of the existence of IVUS 20 years from now (to be rated from 0 – 
uncertain, to 10 - certain). These questions were inserted to quantify the future perspective of IVUS 
technology in the respondents’ opinion. Next, we asked what the reimbursement procedure was for new 
medical devices in the respondent’s country of residence before to specifically address the status of IVUS 
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reimbursement. Then, we asked what were the prevailing factors that could explain the continuous but 
limited clinical utilization of IVUS in the respondents’ opinion. Interventional cardiologists were 
specifically asked how IVUS helps them complete the regular tasks of their job. These questions were 
inserted to collect material explaining current IVUS adoption.  The last part was made of questions on 
additional factors likely to impact IVUS innovation (e.g. educational efforts in IVUS, role of patents, and 
competition between actors in the IVUS market). Finally, we provided room for further comments 
related to IVUS technology that the respondents might want to share. 
 
Network analysis | In the second part of the questionnaire, we asked the respondents to indicate the 
frequency and nature of their interaction with other identified actors. We analyzed the level of 
interaction among our deliberative sample of respondents using the social network analysis software 
UCINET (Harvard University, Boston, USA) [111]. A clique analysis was performed, assembling groups 
of four members or more who declared symmetric interactions [112]. Subsequently, we proceeded to a 
hierarchical cluster analysis of the respondents’ adjacency in the network: an algorithm ordered the 
respondents hierarchically based on their level of similarity (amount of clique memberships shared by 
pairs of actors) and their proximity in the network. The result was displayed as a hierarchical clustering 
tree diagram using UCINET (see Figure 1). Having registered the bonds between actors, which informs 
on the professional network architecture, as well as the respondents’ opinions on IVUS technology, we 
could map IVUS controversies and discuss their implications for the future of IVUS in light of the 
hierarchized network architecture. It is important to realize that the individuals who contributed to this 
study represent only a part of a greater professional network, which is a limitation of this study. However, 
we postulate that the group of respondents that was surveyed is representative of the hierarchies and 
opinions present in the IVUS community. 
 
Description of the respondents | With the initial list of potential respondents, 38 international 
institutions were represented (20 American, 9 Dutch, 3 Canadian, 2 Japanese, 2 French, 1 German, and 
1 South Korean). The list comprised the following types of respondents: 
- Fifteen corporate leaders, encompassing existing IVUS companies (Boston Scientific, Volcano, 
Terumo, Infraredx, Silicon Valley Medical Instruments and Colibri Technologies), a company fostering 
competing intravascular technologies, two general medical ultrasound companies, and a clinical research 
organization with experience in interventional cardiology. The response rate among corporate leaders 
was 40% (6/15).  
- Fourteen cardiologists conducting clinical research involving IVUS or practicing IVUS-guided 
percutaneous coronary interventions (PCI). The group identified comprised key opinion leaders as well 
as international cardiologists in activity performing IVUS related research. The response rate was 57% 
(8/14). 
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- Ten engineers involved with IVUS innovation or related fields. This included two academic engineers 
who filed constitutive IVUS inventions, four academic engineers currently in activity as well as four 
corporate engineers. The response rate was 70% (7/10). 
- Ten funders involved with IVUS innovation or related fields. Six were public funders and four private 
funders. Public funders represented public research organizations, public technology foundations. Private 
funders encompassed private technology foundations and investment firms. The response rate was 20% 
(2/10). 
 
Of the initial 49 actors, 23 (47%) returned a completed questionnaire. We analyzed the responses by first 
reassigning them into pertinent categories. Among cardiologists (8), a distinction was made between 
opinion-leading cardiologists (3) and principal academic cardiologists (5), based on internal knowledge 
of the field of IVUS and top authors tracking on a biomedical experts platform. Among corporate 
leaders, a distinction was made between IVUS companies (4) and related field companies (2). Public and 
Private funders were merged in a single group because of the limited contributions (2). Finally, engineers 
were divided into academic (5) or corporate engineers (2). 
 
For figure and citation purposes, we labeled IVUS corporate leaders as IVUS Corp Leader, corporate 
leaders in adjacent fields as Adj Corp Leader, opinion leading cardiologists as Lead Cardiol, principal 
academic cardiologists as Acad Cardiol, academic engineers as Acad Eng, corporate engineers as Corp Eng 
and funders as Funder. 
 
RESULTS 
 
Auto-characterization of the respondents | Overall, respondents demonstrated a homogeneously high 
technical knowledge (total average of 8.1) and clinical knowledge (total average of 7.6) of IVUS, indicating 
that we successfully surveyed actors involved at the technical and medical interface of IVUS. The technical 
knowledge was well aligned among all categories of actors. Engineers reported a deficit in clinical knowledge 
(average of 6.0), below cardiologists and corporate leaders, indicating that they do not perceive themselves 
as medical specialists. Market knowledge of the respondents appeared to be more widespread (total average 
of 7.0), above average for opinion-leading cardiologists and corporate leaders and below average for 
principal academic cardiologists. The actors’ knowledge representation of IVUS reimbursement policies 
worldwide was the lowest (total average of 5.0). IVUS corporate leaders and corporate leaders of related 
fields were above average while corporate engineers and funders were below. Cardiologists and academic 
engineers were on average. Corporate leaders naturally appeared to be more focused than the rest on the 
non-technical factors that governing the development of medical technologies. 
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Historical context of IVUS introduction | Twenty years elapsed between the registration of the first 
IVUS patent in 1972 [16] and its transfer to clinical research in the early 1990’s [113], when the 
technology caught the attention of interventional cardiologists willing to visualize coronary artery 
lesions. This was clear, for example, in this response from a historical European actor: 
“As the big worry for cardiac echography was to see through the ribs, the idea of a phased array catheter 
was suggested. But in the meantime, the external linear array proved to be successful. People could see the 
heart and babies. Since the noninvasive approach worked, people forgot about the phased array catheter 
until 1992, when the need for a high resolution technique able to characterize coronary artery lesions 
emerged.” (Acad Eng) 
 
The introduction of IVUS as a high tech medical device followed a classical path. It first started as an 
academic engineering project aiming at developing intracardiac echocardiography in real time. IVUS 
technology eventually found light as a high resolution tool to characterize coronary artery lesions, as a 
result of the academic collaboration of cardiologists and engineers. This was clear, for example, in this 
response about the advantages of IVUS from Canada: 
“It [IVUS] has good penetration through blood and soft tissue, enabling estimation of vessel dimension, 
vessel remodeling, and plaque burden with high sensitivity and specificity in identifying coronary 
calcifications”. (Acad Eng) 
 
The second phase of IVUS introduction was its assimilation by industry. Historically, the industrial 
development and aim given to IVUS was largely shaped by Boston Scientific (BSC). This is evident, for 
example, in this response from the US: 
“In the first 10 years, Mansfield/BSC and CVIS were alone; then BSC bought CVIS and merged their 
platform.” (IVUS Corp Leader) 
 
As Boston scientific is primarily a stent manufacturer, IVUS holds an adjacent technology position 
within the company portfolio. IVUS was positioned as a percutaneous coronary intervention (PCI) 
guidance tool, allowing for peri-interventional planning and assessment of complications. This role is 
clear, for example, in the response of an interventional cardiologist who explains how IVUS helps him 
complete the regular tasks of his job: 
“IVUS-guided PCI: 
1. PRE: Plaque assessment, luminal diameters, stent length sizing. 
2. INTRA: Stent apposition, re-entry in dissected planes, ante/retrograde chronic total occlusion 
(CTO). 
3. POST: thrombus, edge prolapse, dissection, etc.” (Lead Cardiol) 
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This tells us that the use of IVUS evolved from a research diagnostic tool to a PCI intervention guidance 
tool. It raises the question of the role for intracoronary imaging technologies. To date, IVUS technology 
is perceived as well aligned within the product portfolio of IVUS companies. This was reported in this 
response from the US: 
“All companies try to create a coronary artery imaging platform. For Boston Scientific and Terumo, 
IVUS is an adjacent market. For Volcano, Infraredx, it is a central market.” (Funder) 
 
The third stage of the introduction of IVUS is its reimbursement via public health policy. Overall, the 
reimbursement process for a new medical device consists in the following: evidence-based medicine must 
prove benefits in using the technology. Subsequently, randomized clinical trials are to be conducted to 
determine whether the technology leads to an improved effectiveness in terms of patient outcome as well 
as a superior cost-effectiveness than the standard of care. The reality of IVUS reimbursement appears 
contrasted. In the US, the situation was reported as follows: 
“There is no separate reimbursement for IVUS and it must be bundled into the existing Diagnosis-
related group (DRG) for the specific coronary intervention.  A separate set of cost-effectiveness and 
clinical utility data would be required to create stand-alone IVUS reimbursement” (IVUS Corp Leader) 
 
This indicates that IVUS only partially fulfills the usual requirements for the reimbursement of a new 
device. Most notably, it appears that the technology has failed to demonstrate clinical utility. However, a 
clear dissymmetry in the reimbursement of IVUS worldwide is observed by several respondents. This was 
clear, for example, in these responses from the US and from Japan: 
“Separate reimbursement exists in Japan, where IVUS penetration is widely viewed as the deepest in any 
part of the world. This is not circumstantial. The second highest major market penetration is in the US, 
where it is not reimbursed separately but in which specific procedure codes do leave enough room for 
IVUS utilization where necessary. The lowest penetration exists in EU and Asia/Latin America markets 
where per-procedure economics are tightest and no separate reimbursement exists. Thus, while there is 
undoubtedly strong clinical belief in the utility of IVUS, there is an undeniable correlation between 
where that clinical belief manifests and where the economic policies are most accommodating.” (IVUS 
Corp Leader) 
 
Japan’s separate reimbursement of IVUS is unique worldwide and seems to be the result of a specific 
society willingness to integrate high-quality, high-tech care in interventional cardiology. Yet, the status of 
IVUS reimbursement is a strong indicator of a contrasted acceptance of the technology and reveals that 
IVUS must be engaged into a set of controversies. 
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Open debates surrounding IVUS technology | IVUS adoption is scarce outside of academia. By 
reviewing the contributors’ answers, we identified six ‘controversies’ revolving around IVUS technology; 
a controversy being defined as a debate surrounding a technique that has not yet been determined [114]. 
The controversies identified are reported in Table 1. 
 
Table 1. Classification of the IVUS controversies conveyed by the respondents 
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- The first controversy concerns the invasive nature of IVUS. It opposes actors that perceive invasiveness 
as a limitation, e.g. by preventing the screening of asymptomatic patients, to actors who relativize the 
minimal invasiveness of IVUS in light of the interventional nature of their job. 
- The second controversy identified concerns the resolution of IVUS. It opposes actors who perceive 
IVUS resolution as insufficient to detect important features of atherosclerotic plaques (e.g. thrombi, thin 
cap fibroatheroma, plaque composition) and/or consider IVUS images as difficult to interpret, to actors 
who praise the sufficient clarity of IVUS whose resolution provides well validated quantitative 
measurements of atherosclerotic plaques (e.g. size and shape of coronary lesions, residual lumen, calcium 
detection, clear images of stent struts). 
- The third controversy concerns the practicability of IVUS as a diagnostic tool. It opposes actors who 
consider that IVUS is an expensive and  late diagnostic solution (restricted to patients who already need an 
intervention) which is tedious to analyse, to actors who praise the local knowledge of the plaque provided 
by IVUS and therefore its prognostic value, as well as the fact that IVUS is relatively quick to use. 
- The fourth controversy concerns the utility of IVUS as a percutaneous coronary intervention (PCI) 
tool. It opposes actors considering that IVUS has a limited impact on clinical decision making and failed 
to prove clinical benefits in terms of PCI treatment outcome, to actors who consider that IVUS improves 
safety overall by resolving ambiguous anatomy on angiograms (for example at the left main coronary 
artery), permitting an adequate selection of stent landing zones and stent size, and allowing for the 
evaluation of post-intervention complications. 
- The fifth controversy concerns the impact of IVUS reimbursement on IVUS utilization worldwide. It 
opposes actors who consider that IVUS current reimbursement leaves enough room for an appropriate 
and that expansion is primarily limited by the lack of demonstrated IVUS benefits, to actors who 
consider that a separate reimbursement of IVUS, even for diagnostic use, would favour its development 
as observed in Japan. 
The sixth controversy concerned the means invested in the formation of IVUS experts. In light of the 
absence of clearly demonstrated clinical benefits in using IVUS, some actors consider that enough 
educational efforts are consented (live cases at conferences, publications, experts visits), while others 
consider that because IVUS technology is not exploited at its full potential, a global educational efforts is 
required (e.g. exposure of cardiologists in training, creation of a certification program, online consulting 
systems).  
 
It is interesting to notice that only one of the six controversies identified - the ongoing debate on IVUS 
resolution - was intrinsic to the technology itself. All others appeared as adjacent debates surrounding 
IVUS practice and questioning aspects of interventional cardiology practice in general. Nonetheless, the 
amount of controversies identified is not negligible and raises the question of the future of IVUS, 
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especially since the field of intracoronary imaging has become more competitive with the introduction of 
OCT. In particular, the role of intravascular imaging seems to be questioned: is the goal to mimicking 
histology, to perform prognostic imaging and/or to provide procedure guidance? 
 
Mapping IVUS controversies | In order to analyze controversies as a function of the network 
architecture, we generated a hierarchized representation of respondents based on their centrality in the 
network and projected their opinion in the tree diagram obtained (Methods section). In Figure 1, we 
projected the actors’ answers mentioning resolution in response to the question of the disadvantages of 
IVUS. By doing so, we map the controversy of IVUS resolution that was identified earlier as the only one 
intrinsic to the technology of IVUS. It appeared that the six most central actors in the network perceive 
IVUS resolution as insufficient. Interestingly, the figure reveals that none of the historic actors (marked 
with a star in the figure) cited resolution as a disadvantage of IVUS. Historically, they introduced IVUS 
as a high resolution technique, filling a void in interventional cardiology. In fact, Figure 1 displays the 
evolution of the debate on resolution. We know that IVUS image quality is the same since its 
introduction. Still it changed from high to low at the advent of OCT. A clear change in understanding of 
what “high resolution” means is observed, independent from the developmental path of IVUS 
technology: it indicates a mutual shaping between technology and society. 
 
 
 
Figure 1. Resolution as limitation projected on hierarchical clique membership graph. Early actors are 
indicated with a star. Actors that were the least central in the network, who declared a limited level of 
interaction with other members, appear at the bottom of the diagram. The diagram can be subdivided as 
follows: a base of peripheral actors that are the least central in the network, a middle group, including early 
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IVUS actors, with an intermediate centrality level, and finally the leading group of the network gathering 
the most central actors. 
Future perspective for IVUS technology | When looking at the distribution of the answers of the 
respondents to the two central questions (the room for improvement left for IVUS technology and the 
perspective of existence in 20 years), we observed a singular double peaked distribution (Figure 2). 
 
 
 
Figure 2. Distribution of answers of the respondents to the questions on IVUS perspective. 
 
This result clearly indicates that two populations coexist in the IVUS network surveyed, one optimistic 
and one pessimistic about the technology perspective. We rearranged the responses into two categories, 
the positive opinions (values above 6) and the negative opinions (values below 6). Academic engineers 
were the most optimistic when rating the room for improvement that IVUS technology has (average of 
7.8), which is natural considering that they are professionally invested in IVUS innovation. Principal 
academic cardiologists were optimistic as well (7.3) followed by IVUS corporate leaders (6.8). On the 
contrary, corporate engineers appeared pessimistic (4.5) while other corporate leaders were the most 
pessimistic (1.5). Logically, it appears that the judgment on the room for improvement of IVUS is 
directly dependent on the degree of investment the actors have in IVUS: engineers and corporate leaders 
involved with other intravascular technologies were negative on the innovation potential of IVUS. 
Results were projected on the tree diagram in Figure 3, showing that historic actors emerge as the 
principal subgroup sharing a positive opinion about the room for innovation left in IVUS. Central 
actors, who are currently professional active, conveyed a rather negative opinion. 
 
Concerning the existence of IVUS in 20 years, the optimistic group gathered principal academic 
cardiologists (7.1), academic engineers (6.6) and IVUS corporate leaders (6.5). The pessimistic group was 
made of the opinion-leading cardiologists (4.3), other corporate leaders (4.0) and funders (3.3). Engineers 
and IVUS corporate leaders were convinced of the future of the technology. Conversely, opinion-leading 
cardiologists and funders were skeptical about the future of IVUS. Again, historic actors shared an 
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optimistic vision of the future of IVUS as for the previous question. Central actors in the network appeared 
more balanced. Actors with a low centrality (potentially less tied to IVUS) were rather pessimistic. 
 
 
 
Figure 3. Room for innovation in IVUS as perceived by the respondents. Early actors are indicated with a 
star. Least central actors in the network appear at the bottom of the diagram and most central actors at the 
top. 
 
When the answers to both questions are coupled, it appears that academic engineers, principal academic 
cardiologists and IVUS corporate leaders share a globally optimistic view, whereas opinion-leading 
cardiologists, other corporate leaders and funders shared a globally pessimistic view. Therefore, a major 
conclusion is that opinion-leading cardiologists and funders, who orientate innovation due to their 
position, disclosed a pessimistic opinion of the existence of IVUS technology 20 years from now. Their 
regard on the future of the technology was clearly exposed, for example, in this response from the US: 
“In my opinion, the use of IVUS only makes sense as part of conventional angioplasty. If it were 
incorporated as part of the procedure, then there would not be a need for a second invasive procedure.  
However, the fact that IVUS is invasive may limit its capability for growth, especially if non-invasive 
MRI and CT coronary diagnostic imaging capabilities reach the point that they become more attractive, 
competitive diagnostic procedures. This may be possible in the near future, and might decrease the need 
for invasive diagnostic procedures like IVUS. 
A more important consideration would be the results of comparative effectiveness studies of IVUS, 
compared to conventional angioplasty. If it could be proved that IVUS increased longevity or 
decreased complications, this would contribute toward making this procedure more attractive to 
practitioners” (Funder) 
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DISCUSSION 
 
This study demonstrates that the development and positioning of IVUS, in the high-tech environment 
of interventional cardiology adjunctive devices, is shaped by co-developing controversies surrounding the 
technology. We questioned why IVUS neither expanded nor disappeared since its introduction 40 years 
ago. The capacity of IVUS to estimate total coronary plaque burden was almost unanimously reported by 
the respondents and appears as the principal advantage of IVUS. Plaque burden can only be measured in 
vivo with IVUS [115] and was shown to be a predictor of major adverse cardiovascular events [18]. For 
this reason, the technology is praised in cardiovascular research since it allows for longitudinal studies of 
atherosclerosis progression. IVUS can also rely on an extensive publication database that makes it the 
standard technology to compare when new intravascular imaging technologies. We can therefore assume 
that it is the utilization of IVUS in cardiovascular research that kept the technology alive in academic 
medical centers. On the other hand, the fact that IVUS failed in demonstrating clear benefits in terms of 
patient outcomes appears as the strongest factor that prevents its expansion - outside Japan at least. The 
case of Japan is illustrative of the mutual shaping between science, technology and society. This was clear, 
for example, in this response from the US: 
“In IVUS the forerunner is certainly Japan with a stricter regulatory process, however combined with a 
higher willingness to use new technologies to improve patient safety and care.” (Corp Eng) 
 
IVUS adoption in Japan can only be explained by distinct society views in healthcare. This observation 
illustrates that IVUS technological advancements result from a mutual shaping between science and 
society rather than from undisputed scientific facts only. Several other lessons, relevant for both the 
future of IVUS and the introduction of new intracoronary imaging techniques, can be learned from this 
sociological study of IVUS innovation. 
 
First, we observed that the only controversy intrinsic to IVUS technology itself was the debate on IVUS 
resolution. Looking at the hierarchical architecture of the IVUS actor-network surveyed is important to 
evaluate the implications of this debate on resolution. The tree diagram (Figure 1) can be subdivided in 
three groups: a base of peripheral actors that are the least central in the network, a middle group of early 
IVUS actors with an intermediate centrality level and finally, the leading group of the network gathering 
the most central actors. Actors at the top of the diagram are likely to be in close collaboration and/or 
competition with each other and to be the most deeply involved with IVUS or adjacent technologies. 
Furthermore, their point of view is dominant because of their central position in the network. But they 
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are also likely to have the highest interest in promoting a given imaging modality. Since the six most 
central actors in this survey are all indicating that IVUS resolution is insufficient, we can assume that the 
future of IVUS technology will depend from its capacity to improve on that front. Interestingly, we 
observed that the middle group of early actors who were involved with the introduction of IVUS pointed 
at other IVUS limitations than resolution. Certainly because, from their perspective, IVUS filled a void 
in the interventional cardiology space and entered as a high resolution modality. On the contrary, 
peripheral actors is likely to be involved to a lesser extent with IVUS and judges potentially a more 
objectively the advantages and disadvantages of IVUS technology. More than resolution, it is the 
ambiguity of IVUS images that they incriminate, telling us that understanding IVUS images requires 
expertise. Whether a higher resolution will solve image interpretation issues is not clear: despite its 
microscopic resolution, OCT is still in a phase of standardization, proven benefits are yet to be 
demonstrated and as for any modality the technology is not exempt of artifacts affecting image 
interpretation. This raises the issue of the training of experienced IVUS users. Several respondents 
stressed the need for focused educational programs in order to fully realize the potential of intracoronary 
imaging techniques, independent from their resolution. Several actors criticized the lack of exposure of 
medical doctors to these techniques at resident stage. Educational efforts in IVUS were considered as 
“hobbyist” by an early European practitioner. Such efforts were questioned by others given the poor 
penetration of IVUS.   
 
Second, most central actors in the network had a skeptical perception of the potential for innovation that 
IVUS technology has left (Figure 3). This can be understood from a historical perspective: the field of 
IVUS faced a relative lack of IVUS innovation in the past 20 year. 40 MHz IVUS was reported as early as 
1991 in scientific literature [116] and remains the standard product of major IVUS companies today. 
Image quality in IVUS did not experience any breakthrough in 20 years. Several respondents criticized 
the lack of competition in the IVUS market that stifles innovation, and call for new start-ups to re-
energize clinical translation. Patents are considered to play minor role to date as they mostly expired. In 
some cases though, IVUS companies happened to sit on innovation therefore limiting the dissemination 
of new technological developments [e.g. palpography]. Despite this overall negative judgment, academic 
engineers as group appeared to be clearly positive about the potential left for IVUS innovation (Figure 2). 
Novel technological solutions can be envisioned at an academic level, in particular to improve IVUS 
resolution. For example, it is well known that the axial resolution in ultrasound imaging can be enhanced 
by shifting to higher frequencies. This applies to IVUS as well and is being pursued academically and 
industrially. However, since the laws of Physics impose a tradeoff between ultrasound frequency and 
ultrasound attenuation, high frequency IVUS is achieved at the cost of imaging depth. Because the added 
value of IVUS comes from its imaging depth, that enables total plaque burden assessment, the room to 
improve axial resolution is limited. Yet, a significant enhancement in IVUS image quality could be 
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achieved by improving IVUS lateral resolution [117], which is currently three times worth than axial 
resolution [44]. When characterizing themselves, engineers declared a deficit in clinical knowledge of 
IVUS compared to other groups, whereas technical knowledge was homogeneously high among actors. A 
more extensive education of engineers to the reality of clinical procedures and catheter laboratory 
workflow might prove to be critical to for the successful introduction of future intracoronary imaging 
modalities. Complementarily, educating interventional cardiologists further in the physics of 
intravascular imaging could improve patient treatment, by helping them to recognize image artifacts to 
secure their diagnostic. Maximizing the IVUS knowledge overlap of interventional cardiologists, 
biomedical engineers, industry leaders and investors would accelerate technological developments. 
 
Third, as five of the six controversies that were identified are external to IVUS technology, we can 
hypothesize that decision making at the industrial, financial and regulatory levels will orientate 
predominantly future innovations in intracoronary imaging. As reported earlier, a major conclusion is 
that opinion-leading cardiologists and funders, who orientate innovation to a large extent, disclosed a 
pessimistic opinion of the existence of IVUS technology 20 years from now. In general, minimally 
invasive imaging modalities are logically not perceived as adequate for the early screening of coronary 
atherosclerosis in asymptomatic patients. First, because the information they provide is local (as opposed 
to a full view of the coronary anatomy e.g. angiography/MRI/CT) and second because of their invasive 
character. Therefore, wide adoption of intravascular imaging will depend on potential added benefits for 
cardiac patients requiring intervention - to be proven through clinical trials. If a medical consensus 
advocates the identification of flow limiting lesions, then FFR and angiography are sufficient. If medical 
guidelines state that the assessment of plaque vulnerability is critical, then intravascular imaging 
techniques will play a role as diagnostic tools. A range of signal processing techniques of IVUS 
radiofrequency data, namely e.g. IVUS flow, IVUS palpography or contrast-enhanced IVUS, can 
augment IVUS capacity to characterize plaque vulnerability. Those modalities do not require extra 
hardware and can therefore be achieved at no extra cost. In the case of OCT, recent developments as 
tissue characterization might become useful [118]. Intravascular photoacoustics holds promises for depth 
resolved coronary wall lipid detection [119, 120]. In any case, next generation IVUS as well as new 
intravascular technologies will compete with OCT in terms of image quality and guidance of stent 
apposition, and with the combination of FFR and angiography in terms of clinical decision making 
[121]. 
 
If the future of IVUS as a stand-alone modality appears uncertain, the technology appeal could be 
renewed by improving lateral resolution and through combination with one or several other imaging 
modalities. To date, IVUS remains the only clinical tool capable of imaging plaque burden in vivo. 
Combination devices were suggested by several respondents as potential solutions to establish coronary 
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plaque vulnerability. For example, the combination of IVUS and OCT would provide OCT resolution 
and IVUS penetration simultaneously. The approach is appealing from an engineering or cardiovascular 
research perspective, but may not be cost effective in routine practice. Catheters are currently expensive 
and sparsely reimbursed disposables. Miniaturization and integration issues tend to increase costs. The 
development of intravascular imaging modalities like intravascular photoacoustics that couples light and 
sound may be an alternative: on top of photoacoustic images, a photoacoustic probe is also capable of 
generating IVUS images by design. In any case, the transfer of intravascular technologies in routine 
clinical practice and their reimbursement will be conditioned by a demonstration of clear clinical benefits 
and cost effectiveness, but also a higher willingness of care practioners to get experience in intravascular 
imaging in order to improve patient safety. Unless of course, in the advent of preventive medicine, 
percutaneous coronary intervention practice decreases drastically. 
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Overview and Perspectives 
 
 
STATE OF THE ART IN IVUS 
 
Intravascular ultrasound (IVUS) celebrated recently its 40 years of existence, as the first patent related to 
the technology was filed in 1972. IVUS consists in a miniaturized echography unit mounted at the tip of 
a catheter. It was developed to provide high resolution images of coronary artery wall structures from the 
inside. A side looking piezoelectric transducer with a typical frequency of 40 MHz is mechanically 
rotated to acquire cross sectional images of the arterial wall, perpendicular to the catheter axis. IVUS 
generates circular grayscale images displaying the envelope of ultrasound pulse/echo radiofrequency data, 
with a resolution of the order of 100 microns along the depth axis (axial resolution) and 300 microns in 
the radial direction (lateral resolution). 
 
Several innovations are currently pursued to enhance IVUS image quality further and consequently 
foster IVUS prognostic value. High frequency IVUS (SVMII, Freemantle, CA, USA) relies upon 
broadband high frequency transducers to offer a finer axial resolution. Next to conventional 40MHz 
IVUS images, the system can generate co-registered 60 MHz IVUS images featuring an axial resolution 
below 60 microns. The enhanced resolution will help detecting thin cap fibroatheromas, an established 
marker of atherosclerotic plaque vulnerability, as well as stent struts malapposition. In addition, 
conventional 40 MHz IVUS images provide deeper structural information of the arterial wall, such as 
the total atherosclerotic plaque burden. At an academic level, Chandrana et al [117] demonstrated the 
feasibility of second-harmonic IVUS with broadband focused IVUS transducers. Interestingly, this 
solution was foreseen by Martijn Frijlink in the concluding remarks of his PhD thesis [122] and could 
drastically enhance IVUS image quality by improving lateral resolution, currently three times worth than 
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IVUS axial resolution [44]. High resolution focused intravascular ultrasound catheters may be 
commercialized in the near future. Finally, IVUS detection capabilities can be augmented when 
combined with an ultrasound contrast agent. Ultraharmonic IVUS, a method introduced in this thesis, is 
capable of detecting a microvascular network below the limit of conventional IVUS. Ultraharmonic 
IVUS imaging has a role to play in the in vivo detection of intraplaque vasa vasorum, one of the most 
robust predictors of plaque vulnerability [3]. 
IVUS technology has also been increasingly combined with optics in the past few years. The association 
of near-infrared spectroscopy and IVUS (Infraredx, Burlington, MA, USA) aims at augmenting the 
morphological information provided by IVUS with local information on the arterial lipid content. Such 
a multimodal approach could tremendously improve the detection of lipid-rich plaques that are 
recognized by interventional cardiologists as prone to rupture. 
IVUS has also been combined with optical coherence tomography (OCT) [123] to take advantage of the 
wide imaging range of IVUS and the ultrahigh resolution of OCT that allows for the clearer detection of 
thin cap fibroatheromas, macrophages and stent struts. Moreover, the fact that OCT requires flushing of 
the arterial lumen will enhance IVUS image quality as well by reducing ultrasound attenuation. A third 
approach combining light and sound is intravascular photoacoustics or IVPA [119]. Contrary to near 
infrared spectroscopy, IVPA can generate depth-resolved cross sectional maps of the arterial wall lipid 
content. As the method relies on the coupling of a laser and an IVUS transducer, IVPA can also generate 
IVUS images of the arterial wall morphology at no cost. 
 
CONTRIBUTION OF THIS THESIS TO THE FIELD OF IVUS 
 
To date, the size distribution of an ultrasound contrast agent after administration in vivo is largely 
unknown. Organs such as the lungs filter large contrast microbubbles while recent evidence indicates 
renal retention of ultrasound contrast agents as well. In consequence, the size distribution of a contrast 
agent is likely to be altered at each re-circulation. Insights in the dynamics of contrast agent size 
distributions in vivo could help tailoring ultrasound contrast agents dedicated to specific ultrasound 
examinations. In the second chapter of this thesis, we show that it is possible to estimate with a single 
transducer the size distribution of an ultrasound contrast agent by insonifying individual contrast 
microbubbles at IVUS frequency (25 MHz). In practice, we report that bubble size is derived from three 
parameters: the distance between a single bubble and the transducer, the incident pressure impinging on 
the bubble and the pressure backscattered on the transducer surface. In vivo feasibility might become 
possible thanks to recent developments in ultrafast ultrasound imaging. By calibrating both in transmit 
and receive the acoustic field of a 3D ultrasound probe and subsequently recording individual 
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microbubble scattering events in vivo, one may estimate the size distribution of an ultrasound contrast 
agent in a given organ. 
 
In the third chapter, we show that a contrast-enhanced IVUS pullback can be used to reconstruct a 
microvascular structure invisible in conventional IVUS. Another goal of this study was to evaluate the 
accuracy of contrast IVUS reconstructions of microchannel diameters. We report that for channel 
diameters within IVUS axial resolution but below lateral resolution, channel diameter reconstructions 
were accurate, while for channel diameters inferior to both IVUS axial and lateral resolution, channel 
diameters detected with contrast IVUS were overestimated. Contrast IVUS is capable of detecting and 
reconstructing a simple microvascular structure but somewhat logically, contrast IVUS resolution cannot 
be enhanced beyond the transducer point spread function. A limitation of this study was that the absence 
of a sensitive IVUS contrast detection mode. As a consequence, we used a high dose of ultrasound 
contrast agent and the 3D reconstruction relied upon an arbitrary threshold level to disentangle contrast 
agent signals from tissue signals. 
 
In the fourth chapter, we report the use of engineered transmission pulses in the field of IVUS. We show 
that short frequency-swept sine excitations, or chirps, can enhance the penetration depth of IVUS 
imaging while preserving the same acoustic pressure level than conventional IVUS pulses. Ultrasound 
chirp imaging could facilitate the study of large coronary arteries and improve side branches visualization. 
In addition, the use of chirps in IVUS allowed for the implementation of a contrast detection technique 
named chirp reversal, which is adapted to the current bandwidth limitations of commercial IVUS 
transducers. When excited with time reversed chirps, the transient resonant response of contrast agents 
generates dissymmetric echoes. On the contrary, biological tissue generates symmetric time reversed 
echoes. This phenomenon enabled the selective detection of ultrasound contrast agents with IVUS. This 
study is the first report of the feasibility of chirp reversal contrast imaging at high frequency. The 
implementation of chirps in IVUS imaging also revealed limitations specific to this technology. In IVUS, 
the transducer can be in direct contact with diseased arterial wall structures that require most attention. 
The temporal window for chirp transmission is therefore limited because a transducer cannot record 
echoes when it is active. As a consequence, the time - frequency bandwidth product of IVUS chirps 
transmitted is limited, which directly correlates to gain in penetration and resolution. A solution to this 
problem could be to move back to an IVUS catheter design where the transducer is positioned along the 
catheter axis inside the shaft, and the ultrasound beam deflected with a rotating mirror. This solution 
artificially elongates the acoustic path between the transducer and arterial wall, granting more time for 
the transmission of longer ultrasound pulses.  
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In the fifth chapter, we introduce ultraharmonic IVUS and compare its performance to chirp reversal 
IVUS for the detection of vasa vasorum sized channels. Both methods have limited bandwidth 
requirements and were successfully implemented on an IVUS probe with a conventional frequency 
bandwidth (<60%). In the case of ultraharmonic IVUS, the use of a pulse inversion sequence was 
necessary to extract ultraharmonic content that is overshadowed by transmit frequency energy otherwise. 
The two pulse sequences dedicated to the detection of ultrasound contrast agents are complying with 
current IVUS systems limitations and should therefore facilitate the translation of contrast IVUS 
imaging to clinical practice. If broader IVUS transducers bandwidths become available, one could think 
of a contrast mode relying on both subharmonics and ultraharmonics of ultrasound contrast agents. The 
contrast mode sensitivity could increase by up to 6 dB. However, coded excitations transmitted for 
contrast detection do not provide the highest resolution B-mode resolution. IVUS should therefore be 
operated in pulse sequences comprising at least one pulse at the transducer center frequency for high 
resolution imaging of tissue together with one or several pairs of engineered pulses dedicated to contrast 
detection. This way IVUS will display co-registered morphological and vascular information on the 
arterial wall. Operating at higher frame IVUS rates is not a technical challenge. 
 
In the sixth chapter, we report the first in vivo ultraharmonic IVUS image of an intricate microvascular 
network, clearing way towards the translation of the method to coronary vasa vasorum detection in 
humans. Ultraharmonic IVUS imaging revealed vascular targets below the resolution limit of IVUS, 
without facing blood flow limitations as in ultrasound Doppler imaging. The method is ready for 
implementation on a clinical IVUS platform and should be tested in a coronary atherosclerosis animal 
model. As marketed ultrasound contrast agents differ in terms of nonlinear properties [124], testing 
several agents in combination with an ultraharmonic IVUS sequence might be valuable in order to 
establish optimal examination guidelines. Studies should also be undertaken to determine the correlation 
between vasa vasorum density and the advancement of coronary atherosclerosis. Ultraharmonic IVUS 
has a role to play in vascular biology studies of atherosclerosis and early diagnostic of coronary plaques at 
risk. Furthermore, it could also be a valuable tool for the longitudinal monitoring of neoangiogenesis on 
stented sites. 
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LESSONS LEARNED THROUGH A SOCIOLOGICAL STUDY  
OF IVUS INNOVATION 
 
In the last chapter of this thesis, we discussed the perspective of IVUS technology in light of sociology of 
innovation. We conducted the survey of an international group of IVUS experts and collected their 
opinions on IVUS innovation. Their answers were analyzed in the scope of sociology of innovation. An 
important finding was that central actors in the network cast a rather negative judgment of the 
innovation potential remaining for IVUS technology and specifically pointed at IVUS resolution. 
Understanding what “high resolution” means in intravascular imaging was redefined with the 
introduction of OCT. One can conclude that the future of IVUS will depend on its capacity to 
demonstrate substantial improvements in image quality. IVUS development may come from 
multimodality devices that can rely on IVUS imaging depth to characterize total plaque burden as well as 
from another modality for the detection of plaque components associated with high risk of plaque 
rupture. In any case, competition in the field of adjunctive devices for percutaneous coronary 
interventions has become fiercer for IVUS, which failed to demonstrate to date added clinical benefits in 
terms of patient treatment outcome. 
In the meantime, a focused collaborative effort between cardiologists, engineers and industrial partners is 
desired in order to realize the full potential of IVUS in the clinic. IVUS has survived to date as a niche 
technology in a few academic medical centers and is mostly praised for clinical research, rather than 
routine clinical practice. 
Beyond the situation of IVUS, it is the role of intravascular imaging of the coronary arteries which is 
questioned here. Resolution is important but intravascular imaging is not aiming at replacing histology. 
The goal of intravascular imaging is twofold: to position itself as a prognostic tool for cardiac patients at 
risk who already require a percutaneous coronary intervention (PCI), as well as a PCI-guidance tool to 
reduce stent failure and monitor complications. 
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POTENTIAL INNOVATIONS IN IVUS IMAGING 
 
Improving resolution appears necessary to leverage IVUS adoption and bridge a part of the gap with 
OCT. But this should be preferably achieved without losing imaging depth as it is the primary strength 
of IVUS. Embettering IVUS lateral resolution seems to be the most relevant option. IVUS lateral 
resolution is currently three times worse than axial resolution. Generating IVUS images with similar axial 
and lateral resolution would drastically improve image quality. Some technical solutions already exist, 
such as annular transducer arrays [125]. Second harmonic tissue imaging could be additionally 
implemented on such arrays to enhance image quality further. 
In addition, IVUS would gain in relying on pulse sequences to display complementary co-registered 
imaging modalities. One could think of combining the following pulses in a single sequence: 
- Short IVUS pulses at the transducer center frequency to generate high-resolution morphological IVUS 
image of reference. 
- IVUS chirps with an optimized time-bandwidth product to visualize the total plaque burden in large 
vessels and/or investigate side branches deeper. 
- Lower frequency pulses for second harmonic tissue imaging, in order to improve lateral resolution and 
reduce stent reverberation artifacts. 
- Pairs of pulses dedicated to contrast-enhanced ultraharmonic IVUS, which enables the delineation of 
the lumen contour without ambiguity and can detect microvasculature infused with an ultrasound 
contrast agent. 
Moving back to an IVUS catheter design where the ultrasound beam gets deflected by a rotating mirror 
could also present significant advantages. Since the travel path of IVUS pulses inside the catheter would 
increase, transducer ring-down effects could be reduced and IVUS images of arterial wall structures in 
direct contact with the catheter sheath could be generated. Moreover, such a design would enable the 
transmission of longer coded excitations. Other academic IVUS innovations such as IVUS flow or 3D 
IVUS palpography could be easily implemented, and might prove to be valuable in characterize shearing 
stress in coronary arteries. In conclusion, by merging in a single sequence all the existing modalities 
derived from the analysis of IVUS radiofrequency signals, one would significantly augment the 
prognostic value of IVUS and its capacity to guide interventions at a low cost. 
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SUMMARY 
 
IMAGING MICROVASCULAR NETWORKS DEEP IN THE HEART 
 
In 2011, an international team of researchers examined more than 50 ancient Egyptian mummies from 
the Middle Kingdom to the Greco-Roman dynasty with a medical X-ray scanner, in search for evidence 
of a major cardiovascular disease: atherosclerosis*. Conclusion: “atherosclerosis is commonplace in 
mummified ancient Egyptians.” 
 
It is safe to say that since antiquity and probably earlier, people are confronted with atherosclerosis, a 
deadly affliction leading to heart attacks and sudden death. In 2008, 7.3 million people worldwide died of 
a heart attack according to the world health organization. 
 
The heart is a central organ that ensures the perpetual transportation of blood and oxygen throughout 
the entire body. What we often forget is that the heart itself requires blood and oxygen to maintain its 
function. This supply is ensured by blood vessels running along the heart surface called coronary arteries. 
Cardiologists now recognize that it is the development of atherosclerosis in the coronary arteries that 
causes heart attacks. To date, the early identification of patient presenting a high risk of cardiovascular 
accident remains a central issue in medicine. 
 
Because a good understanding of diseases at a microscopic scale often leads to new diagnostics and 
treatments, a clear role exists for a medical tool able to visualize coronary atherosclerosis in humans. 
 
Since 1972, researchers of the Erasmus Medical Centre in Rotterdam have been developing echography 
at the tip of a catheter, a technique to navigate inside coronary arteries and image the arterial wall with a 
great level of detail. This technique was named intravascular ultrasound (abbreviated as IVUS) and was 
the first to reveal the shapes and dimensions of atherosclerotic lesions nested in the coronary artery wall. 
40 years later, external imaging techniques, such as echocardiography, MRI and CT, still lack the 
resolution to image coronary artery wall structures, which are too small and lie too deep in the body. 
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Diving deeper and deeper, people realized that the coronary arteries, whose function is to supply heart 
muscle cells with blood and oxygen, were nourished themselves by a network of microvessels that 
penetrate the layers of the arterial wall. This network is called the vasa vasorum, which literally means 
“the vessels of the vessels”. Recent findings indicate that the presence of vasa vasorum inside an 
atherosclerotic coronary lesion was associated with future risks of a heart attack. 
Unfortunately, even IVUS does not have a sufficient resolution to detect the vasa vasorum, which 
exhibits vessel diameters ranging from 200 microns (the diameter of a human hair) down to 5 microns 
(the diameter of a single red blood cell). 
To predict the risk of heart attacks, cardiologists need a tool that can detect coronary vasa vasorum in 
humans. In addition, the method should prove to be safe, reliable and affordable. 
 
Scientists of the Biomedical Engineering department of Erasmus Medical Centre introduced the 
following concept: by injecting microscopic bubbles of the dimension of red blood cells in the blood 
stream, these would eventually enter the vasa vasorum. If one can track with IVUS the signals of these 
bubbles, one could indirectly detect the presence and extent of coronary vasa vasorum. 
 
In this thesis, we present the development of microbubble detection methods for clinical IVUS catheters 
and evaluation of their capacity to detect vasa vasorum sized channels in controlled experiments. 
 
The first method relied on chirps, bio-inspired acoustic signals of increasing or decreasing frequency. 
Chirps are widely used by animals like dolphins or bats for echolocation purposes. Scientists noticed that, 
contrary to biological tissue, a microbubble could generate different echoes in response to an up-sweep 
chirp and an identically shaped down-sweep chirp, through a phenomenon called transient resonance. 
Therefore, by transmitting pairs of up-sweep and down-sweep chirps with IVUS, we were able to sort 
areas filled with microbubbles from areas filled with tissue. In vivo, such an ultrasound detection method 
will permit to image vascular networks infused with microbubbles, while hiding surrounding biological 
structures. 
 
The second method reported relied on the excitation of unique microbubble echoes called 
“ultraharmonics”. Ultraharmonics arise at a frequency which is 1.5 times higher than the transmitted 
frequency and can only be generated by microbubbles. Therefore, imaging microbubble ultraharmonics 
with IVUS is another method to disentangle blood from tissue. In practice, microbubble echoes comprise 
mostly transmit frequency content, which shadows completely the weaker ultraharmonic content. Yet, 
we could extract the ultraharmonic echo’s thanks to a dedicated ultrasound pulse sequence and in this 
manner visualize the microbubbles. 
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We compared both methods and observed that ultraharmonic IVUS imaging was more successful than 
IVUS chirp imaging at detecting of vasa vasorum sized microchannels. We pursued with in vivo 
experiments and demonstrated that ultraharmonic IVUS could successfully image a microvascular 
network of vasa vasorum dimension, below the detection limit of conventional IVUS. The 
ultraharmonic IVUS image showed an excellent agreement with a photograph of the microvascular 
region of interest. 
 
Ultraharmonic IVUS imaging is a method capable of detecting intricate microvascular networks invisible 
with conventional IVUS catheters and could turn into a promising tool for coronary vasa vasorum 
detection in humans. Ultimately, we hope that ultraharmonic IVUS imaging of microvascularization will 
help cardiologists to identify early coronary atherosclerotic lesions presenting risks of heart attacks, and 
therefore limit vast losses of productive life years in our societies. 
 
Beyond the scope of IVUS, the implementation of ultraharmonic ultrasound on conventional 
ultrasound scanners could allow doctors to assess the microvasculature density and therefore the 
inflammatory status of important diseases like atherosclerosis or rheumatoid arthritis. 
 
* A. H. Allam, R. C. Thompson, L. S. Wann, M. I. Miyamoto, A. e.-H. Nur el-Din, G. A. el-Maksoud, M. Al-
Tohamy Soliman, I. Badr, H. A. el-Rahman Amer, M. L. Sutherland, J. D. Sutherland, G. S. Thomas, 
Atherosclerosis in Ancient Egyptian Mummies: The Horus Study. JACC: Cardiovascular Imaging 4, 
315-327 (2011). 
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SAMENVATTING 
 
 
AFBEELDEN VAN MICROVASCULAIRE NETWERKEN DIEP 
IN HET HART 
 
In 2011 lichtte een internationaal team van onderzoekers meer dan 50 oude Egyptische mummies van 
het Middenrijk tot het Grieks-Romeins Rijk door met een röntgenapparaat, op zoek naar bewijs van een 
belangrijke hart- en vaatziekte: atherosclerose*. Hun conclusie luidde: "atherosclerose is gemeengoed in 
gemummificeerde oude Egyptenaren.” 
 
Al sinds de oudheid worden mensen geconfronteerd met atherosclerose, een dodelijke aandoening die 
kan leiden tot hartaanvallen en plotselinge dood. Volgens de World Health Organization stierven in 
2008 wereldwijd 7,3 miljoen mensen aan een hartaanval. 
 
Het hart is het centrale orgaan, dat zorgt voor het continue transport van bloed en zuurstof door het hele 
lichaam. Wat we vaak vergeten is dat het hart zelf ook bloed en zuurstof nodig heeft voor het handhaven 
van zijn functie. Deze voeding wordt geleverd door de bloedvaten die over het hartoppervlak lopen en de 
kransslagaders worden genoemd. Het is algemeen erkend dat de ontwikkeling van atherosclerose in de 
kransslagaders de veroorzaker van hartaanvallen is. De vroegtijdige identificatie van de patiënt met een 
verhoogd risico op een hartaanval blijft echter tot op heden een centraal vraagstuk binnen de 
geneeskunde. 
 
Een goed begrip van ziekten op een microscopische schaal leidt vaak tot nieuwe diagnostiek en 
behandelingen en daarom is er een duidelijke rol weggelegd voor een medisch hulpmiddel dat 
atherosclerose in de menselijke kransslagaders kan afbeelden. 
 
Sinds 1972 houden onderzoekers van het Erasmus Medisch Centrum in Rotterdam zich bezig met het 
ontwikkelen van echografie aan het uiteinde van een katheter, om van binnenuit de wand van de 
kransslagaders gedetailleerd in beeld te brengen. Deze techniek wordt intravasculair ultrageluid (IVUS) 
genoemd en was als eerste in staat de vormen en afmetingen van atherosclerotische laesies in de wand van 
de kransslagaders te onthullen. Nu, veertig jaar later, hebben externe beeldvormende technieken, zoals 
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echocardiografie, MRI en CT, nog steeds niet de benodigde resolutie om de structuren in de vaatwand 
van de kransslagaders in beeld te brengen omdat ze zo klein zijn en erg diep in het lichaam liggen. 
 
Dieper en dieper kijkend, besefte men dat de kransslagaders die de hartspiercellen van bloed en zuurstof 
voorzien, op hun beurt weer gevoed worden door een netwerk van zeer kleine vaatjes die de arteriële 
wand binnendringen. Dit netwerk wordt vasa vasorum genoemd, wat Latijn is voor “de vaten van de 
vaten”. Recente bevindingen wijzen erop dat de aanwezigheid van vasa vasorum binnen een 
atherosclerotische laesie in de kransslagaders verband houdt met het toekomstige risico op een 
hartaanval. 
 
Helaas beschikt zelfs IVUS niet over voldoende resolutie om vasa vasorum te detecteren, dat in diameter 
varieert van 200 micron (de diameter van een menselijke haar) tot 5 micron (de diameter van een enkele 
rode bloedcel). 
 
Om het risico op een hartaanval te kunnen voorspellen, hebben cardiologen een hulpmiddel nodig dat 
vasa vasorum in de kransslagaders van de mens detecteren kan. De methode moet bovendien veilig, 
betrouwbaar en betaalbaar zijn. 
 
Wetenschappers van de afdeling Biomedische Technologie van het Erasmus Medisch Centrum hebben 
het volgende concept geïntroduceerd: in de bloedstroom geïnjecteerde microscopische gasbellen 
(microbellen), in de orde van grootte van rode bloedcellen, zullen uiteindelijk in de vasa vasorum terecht 
komen. Als met IVUS de signalen van deze bellen opgevangen kunnen worden, kan indirect de 
aanwezigheid en omvang van vasa vasorum in de wand van de kransslagaders gedetecteerd worden. 
 
In dit proefschrift beschrijven we de ontwikkeling van twee microbeldetectiemethoden voor klinische 
IVUS katheters en de evaluatie van hun vermogen om kanalen van hetzelfde formaat als vasa vasorum te 
detecteren in gecontroleerde experimenten. 
 
De eerste methode is gebaseerd op tjirps, akoestische signalen, geïnspireerd door de natuur, van 
oplopende of aflopende frequentie. Tjirps worden veel gebruikt door dieren, zoals dolfijnen of 
vleermuizen, voor echolocatie doeleinden. Wetenschappers hebben ontdekt dat een microbel, in 
tegenstelling tot biologisch weefsel, verschillend reageert op een oplopende tjirp en een aflopende tjirp, 
via een verschijnsel dat transiënte resonantie genoemd wordt. Door nu met IVUS paren van oplopende 
en aflopende tjirps te verzenden konden we gebieden met microbellen onderscheiden van biologisch 
weefsel. Met deze techniek kunnen we in vivo plaatjes maken waarop de met microbellen gevulde vasa 
vasorum netwerken duidelijk zichtbaar zijn, terwijl de echo’s van omringende biologische structuren 
onderdrukt worden. 
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De tweede methode die beschreven wordt, gebruikt unieke trillingen van microbellen die gegenereerd 
worden in reactie op ultrageluid.  Deze trillingen hebben een frequentie die anderhalf keer hoger is dan 
de verzonden frequentie en worden alleen gegenereerd door microbellen. Ze worden “ultraharmonische 
echo’s" genoemd. Het afbeelden van deze ultraharmonische trillingen met IVUS is dus een andere 
methode om de bloedvaten van weefsel te onderscheiden. In de praktijk bevatten microbel echo’s echter 
voornamelijk de verzendfrequentie signalen, die de zwakkere ultraharmonische signalen volledig 
overschaduwen. Dankzij een speciale reeks echografie pulsen waren we toch in staat om de microbel 
ultraharmonische echo’s te onderscheiden en op deze manier de microbellen zichtbaar te maken. 
 
We vergeleken beide methoden en constateerden dat de ultraharmonische IVUS methode succesvoller 
was dan de IVUS tjirp methode in het opsporen van kanaaltjes van dezelfde dimensies als vasa vasorum. 
We hebben vervolgens in vivo experimenten uitgevoerd en aangetoond dat ultraharmonische IVUS 
beeldvorming een netwerk van kleine vaten ter grootte van vasa vasorum, en dus onder de detectiegrens 
van conventionele IVUS, met succes in beeld kan brengen. De ultraharmonisch IVUS afbeelding 
vertoonde een voortreffelijke overeenstemming met een foto van het in beeld gebrachte gebied. 
 
Ultraharmonische IVUS beeldvorming is een methode voor het opsporen van ingewikkelde netwerken 
van kleine bloedvaten die onzichtbaar zijn voor conventionele IVUS katheters. Deze nieuwe techniek is 
een potentieel veelbelovend instrument voor vasa vasorum detectie in de kransslagaders van de mens. Wij 
hopen dat ultraharmonische IVUS beeldvorming van vasa vasorum, cardiologen uiteindelijk zal helpen 
bij het vroegtijdig identificeren van atherosclerotische laesies in de kransslagaders, die het risico op een 
hartaanval verhogen, en daarmee grote verliezen van productieve levensjaren in onze samenleving zal 
beperken. 
 
Buiten het kader van IVUS kan de uitvoering van ultraharmonische echografie op conventionele 
echografie apparaten het artsen mogelijk maken om de dichtheid van kleine bloedvaten en daarmee de 
ontstekingsstatus van belangrijke ziekten zoals atherosclerose of reumatoïde artritis te bepalen. 
  
* A. H. Allam, R. C. Thompson, L. S. Wann, M. I. Miyamoto, A. e.-H. Nur el-Din, G. A. el-Maksoud, M. Al-
Tohamy Soliman, I. Badr, H. A. el-Rahman Amer, M. L. Sutherland, J. D. Sutherland, G. S. Thomas, 
Atherosclerosis in Ancient Egyptian Mummies: The Horus Study. JACC: Cardiovascular Imaging 4, 
315-327 (2011). 
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